Camp, Nicola J., PhD

Languages

  • English

Academic Information

  • Departments: Internal Medicine - Professor
  • Divisions: Hematology/BMT
  • Cancer Center Programs: Cancer Control & Population Sciences

Academic Office Information

  • 801-213-5767
  • Huntsman Cancer Institute
    2000 Circle of Hope, Room: RS4271
    Salt Lake City, UT 84112

Academic Bio

Nicola J. Camp, PhD, is a professor in the Departments of Medicine (Division of Hematology and Hematologic Malignancies) and Human Genetics at the University of Utah School of Medicine. She is a Huntsman Cancer Institute investigator, and a member of the Cancer Control and Population Sciences program. As a genetic epidemiologist/statistical geneticist, her research interests include the identification of heritable genetic risk variants and the development of novel methods.

The identification of inherited genetic risk variants is critical in understanding disease mechanisms. However, such discoveries are challenging for complex diseases. Novel methods and study designs play essential roles in addressing these challenges. Certainly there is no guarantee that a new method will produce a leap of knowledge; however, it can be high-impact and cutting edge when it does. The hope is that a better understanding of inherited genetic risk will lead to improvements in prevention, detection, diagnosis, and treatment strategies. Camp’s current research focuses on the identification of germ-line genetic variants that increase susceptibility to breast cancer, chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) and her projects include: whole exome and whole genome massively parallel sequencing in a high-risk CLL pedigree; high-density genomewide SNP genotyping in CLL, MM and controls; and apoptosis candidate pathway genotyping and sequencing in high-risk breast cancer and controls. These projects often involve multi-disciplinary collaborations across campus, in addition to joint research performed within the context of large, national and international consortia.

Camp received her PhD in statistical genetics from the University of Sheffield, UK. She received post-doctoral training in molecular and genetic medicine at the University of Sheffield Medical School, UK. In the past, Camp served on the Graduate Council as the School of Medicine representative and on the University Academic Senate. She has received the Reed Gardner Award for Faculty Excellence, has been honored by the Leukemia and Lymphoma Society for her research and is a recipient of a Presidential Early Career Award for Scientists and Engineers. She currently acts on the editorial board of two genetics journals and is a member of the American Society of Human Genetics, the American Association for Cancer Research and the International Genetic Epidemiology Society.

Research Statement

Nicola J. Camp, PhD, joined the University of Utah in 1998. She is a Mathematician-Statistician trained in genetic epidemiology and statistical genetics in the United Kingdom. She is a Professor in the Division of Hematology and Hematological Malignancies, Department of Medicine, University of Utah School of Medicine and a cancer investigator at Huntsman Cancer Institute in the Cancer Control and Population Sciences research program. She also leads HCI's Womens’ Disease Oriented Team with David Gaffney, MD. Her research focuses on the identification of inherited genetic mutations that increase risk to cancers, specifically breast cancer and hematological malignancies. She often uses the rich genealogy in the Utah Population Database (UPDB) together with cancer diagnoses from the Utah Cancer Registry to study large cancer families. Using her mathematical background, Nicola also develops new statistical methods for genetic studies. Nicola has authored more than 140 publications and mentored over 40 students from the molecular biology, biomedical informatics, and MSTAT programs. More information can be found at http://www.huntsmancancer.org/camplab

Education History

Type School Degree
Postdoctoral Fellowship University of Sheffield, Division of Molecular and Genetic Medicine, School of Medicine
Statistical Genetics
Postdoctoral Fellow
Doctoral Training University of Sheffield, Section of Probability Statistics, School of Medicine
Statistical Genetics
Ph.D.
Undergraduate University of Sheffield
Mathematics
B.Sc.

Global Impact

Education History

Type School Degree Country
Postdoctoral Fellowship University of Sheffield, Division of Molecular and Genetic Medicine, School of Medicine
Statistical Genetics
Postdoctoral Fellow United Kingdom
Doctoral Training University of Sheffield, Section of Probability Statistics, School of Medicine
Statistical Genetics
Ph.D. United Kingdom
Undergraduate University of Sheffield
Mathematics
B.Sc. United Kingdom

Selected Publications

Journal Article

  1. Law PJ, Berndt SI, Speedy HE, Camp NJ, Sava GP, Skibola CF, Holroyd A, Joseph V, Sunter NJ, Nieters A, Bea S, Monnereau A, Martin-Garcia D, Goldin LR, Clot G, Teras LR, Quintela I, Birmann BM, Jayne S, Cozen W, Majid A, Smedby KE, Lan Q, Dearden C, Brooks-Wilson AR, Hall AG, Purdue MP, Mainou-Fowler T, Vajdic CM, Jackson GH, Cocco P, Marr H, Zhang Y, Zheng T, Giles GG, Lawrence C, Call TG, Liebow M, Melbye M, Glimelius B, Mansouri L, Glenn M, Curtin K, Diver WR, Link BK, Conde L, Bracci PM, Holly EA, Jackson RD, Tinker LF, Benavente Y, Boffetta P, Brennan P, Maynadie M, McKay J, Albanes D, Weinstein S, Wang Z, Caporaso NE, Morton LM, Severson RK, Riboli E, Vineis P, Vermeulen RC, Southey MC, Milne RL, Clavel J, Topka S, Spinelli JJ, Kraft P, Ennas MG, Summerfield G, Ferri GM, Harris RJ, Miligi L, Pettitt AR, North KE, Allsup DJ, Fraumeni JF, Bailey JR, Offit K, Pratt G, Hjalgrim H, Pepper C, Chanock SJ, Fegan C, Rosenquist R, de Sanjose S, Carracedo A, Dyer MJ, Catovsky D, Campo E, Cerhan JR, Allan JM, Rothman N, Houlston R, Slager S (2017 Feb 06). Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia. Nat Commun, 8, 14175.
  2. Birmann BM, Andreotti G, De Roos AJ, Camp NJ, Chiu BCH, Spinelli JJ, Becker N, Benhaim-Luzon V, Bhatti P, Boffetta P, Brennan P, Brown EE, Cocco P, Costas L, Cozen W, de Sanjose S, Foretova L, Giles GG, Maynadie M, Moysich K, Nieters A, Staines A, Tricot G, Weisenburger D, Zhang Y, Baris D, Purdue MP (2017 Jun). Young Adult and Usual Adult Body Mass Index and Multiple Myeloma Risk: A Pooled Analysis in the International Multiple Myeloma Consortium (IMMC). Cancer Epidemiol Biomarkers Prev, 26(6), 876-885.
  3. Li J, Li H, Makunin I, Thompson BA, Tao K, Young EL, Lopez J, Camp NJ, Tavtigian SV, John EM, Andrulis IL, Khanna KK, Goldgar D, Chenevix-Trench G (2017 Aug 24). Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families.LID - 10.1007/s10549-017-4469-0 [doi]. (Epub ahead of print) Breast Cancer Res Treat.
  4. Rand KA, Song C, Dean E, Serie DJ, Curtin K, Sheng X, Hu D, Huff CA, Bernal-Mizrachi L, Tomasson MH, Ailawadhi S, Singhal S, Pawlish K, Peters ES, Bock CH, Stram A, Van Den Berg DJ, Edlund CK, Conti DV, Zimmerman T, Hwang AE, Huntsman S, Graff J, Nooka A, Kong Y, Pregja SL, Berndt SI, Blot WJ, Carpten J, Casey G, Chu L, Diver WR, Stevens VL, Lieber MR, Goodman PJ, Hennis AJ, Hsing AW, Mehta J, Kittles RA, Kolb S, Klein EA, Leske C, Murphy AB, Nemesure B, Neslund-Dudas C, Strom SS, Vij R, Rybicki BA, Stanford JL, Signorello LB, Witte JS, Ambrosone CB, Bhatti P, John EM, Bernstein L, Zheng W, Olshan AF, Hu JJ, Ziegler RG, Nyante SJ, Bandera EV, Birmann BM, Ingles SA, Press MF, Atanackovic D, Glenn MJ, Cannon-Albright LA, Jones B, Tricot G, Martin TG, Kumar SK, Wolf JL, Deming Halverson SL, Rothman N, Brooks-Wilson AR, Rajkumar SV, Kolonel LN, Chanock SJ, Slager SL, Severson RK, Janakiraman N, Terebelo HR, Brown EE, De Roos AJ, Mohrbacher AF, Colditz GA, Giles GG, Spinelli JJ, Chiu BC, Munshi NC, Anderson KC, Levy J, Zonder JA, Orlowski RZ, Lonial S, Camp NJ, Vachon CM, Ziv E, Stram DO, Hazelett DJ, Haiman CA, Cozen W (2016 Dec). A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci. Cancer Epidemiol Biomarkers Prev, 25(12), 1609-1618.
  5. Bradford JR, Cox A, Bernard P, Camp NJ (2016). Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment. PLoS ONE, 11(9), e0163238.
  6. Berndt SI, Camp NJ, Skibola CF, Vijai J, Wang Z, Gu J, Nieters A, Kelly RS, Smedby KE, Monnereau A, Cozen W, Cox A, Wang SS, Lan Q, Teras LR, Machado M, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP, Birmann BM, Vajdic CM, Cocco P, Zhang Y, Giles GG, Zeleniuch-Jacquotte A, Lawrence C, Montalvan R, Burdett L, Hutchinson A, Ye Y, Call TG, Shanafelt TD, Novak AJ, Kay NE, Liebow M, Cunningham JM, Allmer C, Hjalgrim H, Adami HO, Melbye M, Glimelius B, Chang ET, Glenn M, Curtin K, Cannon-Albright LA, Diver WR, Link BK, Weiner GJ, Conde L, Bracci PM, Riby J, Arnett DK, Zhi D, Leach JM, Holly EA, Jackson RD, Tinker LF, Benavente Y, Sala N, Casabonne D, Becker N, Boffetta P, Brennan P, Foretova L, Maynadie M, McKay J, Staines A, Chaffee KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Leis JF, Weinberg JB, Caporaso NE, Norman AD, De Roos AJ, Morton LM, Severson RK, Riboli E, Vineis P, Kaaks R, Masala G, Weiderpass E, Chirlaque MD, Vermeulen RC, Travis RC, Southey MC, Milne RL, Albanes D, Virtamo J, Weinstein S, Clavel J, Zheng T, Holford TR, Villano DJ, Maria A, Spinelli JJ, Gascoyne RD, Connors JM, Bertrand KA, Giovannucci E, Kraft P, Kricker A, Turner J, Ennas MG, Ferri GM, Miligi L, Liang L, Ma B, Huang J, Crouch S, Park JH, Chatterjee N, North KE, Snowden JA, Wright J, Fraumeni JF, Offit K, Wu X, de Sanjose S, Cerhan JR, Chanock SJ, Rothman N, Slager SL (2016 Mar 09). Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia. Nat Commun, 7, 10933.
  7. Bradford JR, Wappett M, Beran G, Logie A, Delpuech O, Brown H, Boros J, Camp NJ, McEwen R, Mazzola AM, DCruz C, Barry ST (2016 Apr 12). Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers. Oncotarget, 7(15), 20773-87.
  8. Machiela MJ, Lan Q, Slager SL, Vermeulen RC, Teras LR, Camp NJ, Cerhan JR, Spinelli JJ, Wang SS, Nieters A, Vijai J, Yeager M, Wang Z, Ghesquieres H, McKay J, Conde L, de Bakker PI, Cox DG, Burdett L, Monnereau A, Flowers CR, De Roos AJ, Brooks-Wilson AR, Giles GG, Melbye M, Gu J, Jackson RD, Kane E, Purdue MP, Vajdic CM, Albanes D, Kelly RS, Zucca M, Bertrand KA, Zeleniuch-Jacquotte A, Lawrence C, Hutchinson A, Zhi D, Habermann TM, Link BK, Novak AJ, Dogan A, Asmann YW, Liebow M, Thompson CA, Ansell SM, Witzig TE, Tilly H, Haioun C, Molina TJ, Hjalgrim H, Glimelius B, Adami HO, Roos G, Bracci PM, Riby J, Smith MT, Holly EA, Cozen W, Hartge P, Morton LM, Severson RK, Tinker LF, North KE, Becker N, Benavente Y, Boffetta P, Brennan P, Foretova L, Maynadie M, Staines A, Lightfoot T, Crouch S, Smith A, Roman E, Diver WR, Offit K, Zelenetz A, Klein RJ, Villano DJ, Zheng T, Zhang Y, Holford TR, Turner J, Southey MC, Clavel J, Virtamo J, Weinstein S, Riboli E, Vineis P, Kaaks R, Boeing H, Tjonneland A, Angelucci E, Di Lollo S, Rais M, De Vivo I, Giovannucci E, Kraft P, Huang J, Ma B, Ye Y, Chiu BC, Liang L, Park JH, Chung CC, Weisenburger DD, Fraumeni JF Jr, Salles G, Glenn M, Cannon-Albright L, Curtin K, Wu X, Smedby KE, de Sanjose S, Skibola CF, Berndt SI, Birmann BM, Chanock SJ, Rothman N (2016 Apr 15). Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Hum Mol Genet, 25(8), 1663-76.
  9. Schinasi LH, Brown EE, Camp NJ, Wang SS, Hofmann JN, Chiu BC, Miligi L, Beane Freeman LE, de Sanjose S, Bernstein L, Monnereau A, Clavel J, Tricot GJ, Atanackovic D, Cocco P, Orsi L, Dosman JA, McLaughlin JR, Purdue MP, Cozen W, Spinelli JJ, de Roos AJ (2016 Oct). Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium. Br J Haematol, 175(1), 87-101.
  10. Camp NJ, Lin WY, Bigelow A, Burghel GJ, Mosbruger TL, Parry MA, Waller RG, Rigas SH, Tai PY, Berrett K, Rajamanickam V, Cosby R, Brock IW, Jones B, Connley D, Sargent R, Wang G, Factor RE, Bernard PS, Cannon-Albright L, Knight S, Abo R, Werner TL, Reed MW, Gertz J, Cox A (2016 Apr 01). Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus. Cancer Res, 76(7), 1916-25.
  11. Costas L, Lambert BH, Birmann BM, Moysich KB, De Roos AJ, Hofmann JN, Baris D, Wang SS, Camp NJ, Tricot G, Atanackovic D, Brennan P, Cocco P, Nieters A, Becker N, Maynadie M, Foretova L, Boffetta P, Staines A, Brown EE, de Sanjose S (2016 Jan). A Pooled Analysis of Reproductive Factors, Exogenous Hormone Use, and Risk of Multiple Myeloma among Women in the International Multiple Myeloma Consortium. Cancer Epidemiol Biomarkers Prev, 25(1), 217-21.
  12. Ziv E, Dean E, Hu D, Martino A, Serie D, Curtin K, Campa D, Aftab B, Bracci P, Buda G, Zhao Y, Caswell-Jin J, Diasio R, Dumontet C, Dudzinski M, Fejerman L, Greenberg A, Huntsman S, Jamroziak K, Jurczyszyn A, Kumar S, Atanackovic D, Glenn M, Cannon-Albright LA, Jones B, Lee A, Marques H, Martin T, Martinez-Lopez J, Rajkumar V, Sainz J, Vangsted AJ, Watek M, Wolf J, Slager S, Camp NJ, Canzian F, Vachon C (2015 Jul 22). Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Nat Commun, 6, 7539.
  13. Andreotti G, Birmann BM, Cozen W, De Roos AJ, Chiu BC, Costas L, de Sanjose S, Moysich K, Camp NJ, Spinelli JJ, Pahwa P, Dosman JA, McLaughlin JR, Boffetta P, Staines A, Weisenburger D, Benhaim-Luzon V, Brennan P, Costantini AS, Miligi L, Campagna M, Nieters A, Becker N, Maynadie M, Foretova L, Zheng T, Tricot G, Milliken K, Krzystan J, Steplowski E, Baris D, Purdue MP (2015 Mar). A pooled analysis of cigarette smoking and risk of multiple myeloma from the international multiple myeloma consortium. Cancer Epidemiol Biomarkers Prev, 24(3), 631-4.
  14. Lin WY, Camp NJ, Ghoussaini M, Beesley J, Michailidou K, Hopper JL, Apicella C, Southey MC, Stone J, Schmidt MK, Broeks A, Vant Veer LJ, Th Rutgers EJ, Muir K, Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Peto J, Dos-Santos-Silva I, Fletcher O, Johnson N, Bolla MK, Wang Q, Dennis J, Sawyer EJ, Cheng T, Tomlinson I, Kerin MJ, Miller N, Marme F, Surowy HM, Burwinkel B, Guenel P, Truong T, Menegaux F, Mulot C, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Benitez J, Zamora MP, Arias Perez JI, Menendez P, Gonzalez-Neira A, Pita G, Alonso MR, Alvarez N, Herrero D, Anton-Culver H, Brenner H, Dieffenbach AK, Arndt V, Stegmaier C, Meindl A, Lichtner P, Schmutzler RK, Muller-Myhsok B, Brauch H, Bruning T, Ko YD, Tessier DC, Vincent D, Bacot F, Nevanlinna H, Aittomaki K, Blomqvist C, Khan S, Matsuo K, Ito H, Iwata H, Horio A, Bogdanova NV, Antonenkova NN, Dork T, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Wu AH, Tseng CC, Van Den Berg D, Stram DO, Neven P, Wauters E, Wildiers H, Lambrechts D, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Radice P, Peterlongo P, Manoukian S, Bonanni B, Couch FJ, Wang X, Vachon C, Purrington K, Giles GG, Milne RL, Mclean C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Simard J, Goldberg MS, Labreche F, Dumont M, Teo SH, Yip CH, Hassan N, Vithana EN, Kristensen V, Zheng W, Deming-Halverson S, Shrubsole MJ, Long J, Winqvist R, Pylkas K, Jukkola-Vuorinen A, Kauppila S, Andrulis IL, Knight JA, Glendon G, Tchatchou S, Devilee P, Tollenaar RA, Seynaeve C, Van Asperen CJ, Garcia-Closas M, Figueroa J, Lissowska J, Brinton L, Czene K, Darabi H, Eriksson M, Brand JS, Hooning MJ, Hollestelle A, Van Den Ouweland AM, Jager A, Li J, Liu J, Humphreys K, Shu XO, Lu W, Gao YT, Cai H, Cross SS, Reed MW, Blot W, Signorello LB, Cai Q, Pharoah PD, Perkins B, Shah M, Blows FM, Kang D, Yoo KY, Noh DY, Hartman M, Miao H, Chia KS, Putti TC, Hamann U, Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Sangrajrang S, Gaborieau V, Brennan P, Mckay J, Slager S, Toland AE, Yannoukakos D, Shen CY, Hsiung CN, Wu PE, Ding SL, Ashworth A, Jones M, Orr N, Swerdlow AJ, Tsimiklis H, Makalic E, Schmidt DF, Bui QM, Chanock SJ, Hunter DJ, Hein R, Dahmen N, Beckmann L, Aaltonen K, Muranen TA, Heikkinen T, Irwanto A, Rahman N, Turnbull CA, Waisfisz Q, Meijers-Heijboer HE, Adank MA, Van Der Luijt RB, Hall P, Chenevix-Trench G, Dunning A, Easton DF, Cox A (2015 Jan 01). Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. Hum Mol Genet, 24(1), 285-98.
  15. Darlington TM, Pimentel R, Smith K, Bakian AV, Jerominski L, Cardon J, Camp NJ, Callor WB, Grey T, Singleton M, Yandell M, Renshaw PF, Yurgelun-Todd DA, Gray D, Coon H (2014 Oct 21). Identifying rare variants for genetic risk through a combined pedigree and phenotype approach: application to suicide and asthma. Transl Psychiatry, 4, e471.
  16. Teerlink CC, Thibodeau SN, McDonnell SK, Schaid DJ, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, Easton D, Kote-Jarai Z, Guy M, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Fitzgerald LM, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Wahlfors T, Tammela T, Schleutker J, Wiklund F, Gronberg H, Emanuelsson M, Carpten J, Bailey-Wilson J, Whittemore AS, Oakley-Girvan I, Hsieh CL, Catalona WJ, Zheng SL, Jin G, Lu L, Xu J, Camp NJ, Cannon-Albright LA (2014 Mar). Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease. Hum Genet, 133(3), 347-56.
  17. Andreotti G, Birmann B, De Roos AJ, Spinelli J, Cozen W, Camp NJ, Moysich K, Chiu B, Steplowski E, Krzystan J, Boffetta P, Benhaim-Luzon V, Brennan P, de Sanjose S, Costas L, Costantini AS, Miligi L, Cocco P, Becker N, Foretova L, Maynadie M, Nieters A, Staines A, Tricot G, Milliken K, Weisenburger D, Zheng T, Baris D, Purdue MP (2013 Sep). A pooled analysis of alcohol consumption and risk of multiple myeloma in the international multiple myeloma consortium. Cancer Epidemiol Biomarkers Prev, 22(9), 1620-7.
  18. Coon H, Darlington T, Pimentel R, Smith KR, Huff CD, Hu H, Jerominski L, Hansen J, Klein M, Callor WB, Byrd J, Bakian A, Crowell SE, McMahon WM, Rajamanickam V, Camp NJ, McGlade E, Yurgelun-Todd D, Grey T, Gray D (2013 Nov 19). Genetic risk factors in two Utah pedigrees at high risk for suicide. Transl Psychiatry, 3, e325.
  19. Xu J, Lange EM, Lu L, Zheng SL, Wang Z, Thibodeau SN, Cannon-Albright LA, Teerlink CC, Camp NJ, Johnson AM, Zuhlke KA, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Maier C, Luedeke M, Vogel W, Schleutker J, Wahlfors T, Tammela T, Schaid D, McDonnell SK, DeRycke MS, Cancel-Tassin G, Cussenot O, Wiklund F, Gronberg H, Eeles R, Easton D, Kote-Jarai Z, Whittemore AS, Hsieh CL, Giles GG, Hopper JL, Severi G, Catalona WJ, Mandal D, Ledet E, Foulkes WD, Hamel N, Mahle L, Moller P, Powell I, Bailey-Wilson JE, Carpten JD, Seminara D, Cooney KA, Isaacs WB (2013 Jan). HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet, 132(1), 5-14.
  20. Slager SL, Achenbach SJ, Asmann YW, Camp NJ, Rabe KG, Goldin LR, Call TG, Shanafelt TD, Kay NE, Cunningham JM, Wang AH, Weinberg JB, Norman AD, Link BK, Leis JF, Vachon CM, Lanasa MC, Caporaso NE, Novak AJ, Cerhan JR (2013 Mar). Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes. Cancer Epidemiol Biomarkers Prev, 22(3), 461-6.
  21. Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z, Cozen W, Monnereau A, Wang SS, Kelly RS, Lan Q, Teras LR, Chatterjee N, Chung CC, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP, Birmann BM, Armstrong BK, Cocco P, Zhang Y, Severi G, Zeleniuch-Jacquotte A, Lawrence C, Burdette L, Yuenger J, Hutchinson A, Jacobs KB, Call TG, Shanafelt TD, Novak AJ, Kay NE, Liebow M, Wang AH, Smedby KE, Adami HO, Melbye M, Glimelius B, Chang ET, Glenn M, Curtin K, Cannon-Albright LA, Jones B, Diver WR, Link BK, Weiner GJ, Conde L, Bracci PM, Riby J, Holly EA, Smith MT, Jackson RD, Tinker LF, Benavente Y, Becker N, Boffetta P, Brennan P, Foretova L, Maynadie M, McKay J, Staines A, Rabe KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Lanasa MC, Spector LG, Leis JF, Cunningham JM, Weinberg JB, Morrison VA, Caporaso NE, Norman AD, Linet MS, De Roos AJ, Morton LM, Severson RK, Riboli E, Vineis P, Kaaks R, Trichopoulos D, Masala G, Weiderpass E, Chirlaque MD, Vermeulen RC, Travis RC, Giles GG, Albanes D, Virtamo J, Weinstein S, Clavel J, Zheng T, Holford TR, Offit K, Zelenetz A, Klein RJ, Spinelli JJ, Bertrand KA, Laden F, Giovannucci E, Kraft P, Kricker A, Turner J, Vajdic CM, Ennas MG, Ferri GM, Miligi L, Liang L, Sampson J, Crouch S, Park JH, North KE, Cox A, Snowden JA, Wright J, Carracedo A, Lopez-Otin C, Bea S, Salaverria I, Martin-Garcia D, Campo E, Fraumeni JF Jr, de Sanjose S, Hjalgrim H, Cerhan JR, Chanock SJ, Rothman N, Slager SL (2013 Aug). Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet, 45(8), 868-76.
  22. Lin WY, Brock IW, Connley D, Cramp H, Tucker R, Slate J, Reed MW, Balasubramanian SP, Cannon-Albright LA, Camp NJ, Cox A (2013). Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer. PLoS ONE, 8(7), e68578.
  23. Knight S, Abo RP, Abel HJ, Neklason DW, Tuohy TM, Burt RW, Thomas A, Camp NJ (2012 Nov). Shared genomic segment analysis: the power to find rare disease variants. Ann Hum Genet, 76(6), 500-9.
  24. Slager SL, Camp NJ, Conde L, Shanafelt TD, Achenbach SJ, Rabe KG, Kay NE, Novak AJ, Call TG, Bracci PM, Sille FM, Sanchez S, Akers NK, Cunningham JM, Serie DJ, McDonnell SK, Leis JF, Wang AH, Weinberg JB, Glenn M, Link B, Vachon CM, Lanasa MC, Skibola CF, Cerhan JR (2012 Dec). Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes. Br J Haematol, 159(5), 572-6.
  25. Arrington CB, Bleyl SB, Matsunami N, Bowles NE, Leppert TI, Demarest BL, Osborne K, Yoder BA, Byrne JL, Schiffman JD, Null DM, DiGeronimo R, Rollins M, Faix R, Comstock J, Camp NJ, Leppert MF, Yost HJ, Brunelli L (2012 Dec). A family-based paradigm to identify candidate chromosomal regions for isolated congenital diaphragmatic hernia. Am J Med Genet A, 158A(12), 3137-47.
  26. Cai Z, Thomas A, Teerlink C, Farnham JM, Cannon-Albright LA, Camp NJ (2012 Nov 28). Pairwise shared genomic segment analysis in three Utah high-risk breast cancer pedigrees. BMC Genomics, 13, 676.
  27. Campa D, Butterbach K, Slager SL, Skibola CF, de Sanjose S, Benavente Y, Becker N, Foretova L, Maynadie M, Cocco P, Staines A, Kaaks R, Boffetta P, Brennan P, Conde L, Bracci PM, Caporaso NE, Strom SS, Camp NJ, Cerhan JR, Canzian F, Nieters A (2012 Aug 15). A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk. Int J Cancer, 131(4), 803-12.
  28. Camp NJ, Parry M, Knight S, Abo R, Elliott G, Rigas SH, Balasubramanian SP, Reed MW, McBurney H, Latif A, Newman WG, Cannon-Albright LA, Evans DG, Cox A (2012 Jan). Fine-mapping CASP8 risk variants in breast cancer. Cancer Epidemiol Biomarkers Prev, 21(1), 176-81.
  29. Jin G, Lu L, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Cannon-Albright LA, Camp NJ, Teerlink CC, Fitzgerald LM, Stanford JL, Wiley KE, Isaacs SD, Walsh PC, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, Easton D, Kote-Jarai Z, Guy M, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Thibodeau SN, McDonnell SK, Schaid DJ, Wiklund F, Gronberg H, Emanuelsson M, Whittemore AS, Oakley-Girvan I, Hsieh CL, Wahlfors T, Tammela T, Schleutker J, Catalona WJ, Zheng SL, Ostrander EA, Isaacs WB, Xu J (2012 Jul). Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet, 131(7), 1095-103.
  30. Slager SL, Skibola CF, Di Bernardo MC, Conde L, Broderick P, McDonnell SK, Goldin LR, Croft N, Holroyd A, Harris S, Riby J, Serie DJ, Kay NE, Call TG, Bracci PM, Halperin E, Lanasa MC, Cunningham JM, Leis JF, Morrison VA, Spector LG, Vachon CM, Shanafelt TD, Strom SS, Camp NJ, Weinberg JB, Matutes E, Caporaso NE, Wade R, Dyer MJ, Dearden C, Cerhan JR, Catovsky D, Houlston RS (2012 Jul 26). Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. Blood, 120(4), 843-6.
  31. Bailey-Wilson JE, Childs EJ, Cropp CD, Schaid DJ, Xu J, Camp NJ, Cannon-Albright LA, Farnham JM, George A, Powell I, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Guy M, Edwards S, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Stanford JL, Karyadi DM, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Thibodeau SN, McDonnell SK, Hebbring S, Lange EM, Cooney KA, Tammela TL, Schleutker J, Maier C, Bochum S, Hoegel J, Gronberg H, Wiklund F, Emanuelsson M, Cancel-Tassin G, Valeri A, Cussenot O, Isaacs WB (2012 Jun 19). Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families. BMC Med Genet, 13(1), 46.
  32. Lu L, Cancel-Tassin G, Valeri A, Cussenot O, Lange EM, Cooney KA, Farnham JM, Camp NJ, Cannon-Albright LA, Tammela TL, Schleutker J, Hoegel J, Herkommer K, Maier C, Vogel W, Wiklund F, Emanuelsson M, Gronberg H, Wiley KE, Isaacs SD, Walsh PC, Helfand BT, Kan D, Catalona WJ, Stanford JL, FitzGerald LM, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Whittemore AS, Oakley-Girvan I, Hsieh CL, Powell I, Bailey-Wilson JE, Cropp CD, Simpson C, Carpten JD, Seminara D, Zheng SL, Xu J, Giles GG, Severi G, Hopper JL, English DR, Foulkes WD, Maehle L, Moller P, Badzioch MD, Edwards S, Guy M, Eeles R, Easton D, Isaacs WB (2012 Mar). Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. Prostate, 72(4), 410-26.
  33. Teerlink C, Farnham J, Allen-Brady K, Camp NJ, Thomas A, Leachman S, Cannon-Albright L (2012 Jan). A unique genome-wide association analysis in extended Utah high-risk pedigrees identifies a novel melanoma risk variant on chromosome arm 10q. Hum Genet, 131(1), 77-85.
  34. Carlquist JF, McKinney JT, Horne BD, Camp NJ, Cannon-Albright L, Muhlestein JB, Hopkins P, Clarke JL, Mower CP, Park JJ, Nicholas ZP, Huntinghouse JA, Anderson JL (2011 Jul 10). Common Variants in 6 Lipid-Related Genes Discovered by High-Resolution DNA Melting Analysis and Their Association with Plasma Lipids.LID - 2155-9880-2-138 [pii]. J Clinic Experiment Cardiol, 2(138).
  35. Cai Z, Knight S, Thomas A, Camp NJ (2011 Nov 29). Pairwise shared genomic segment analysis in high-risk pedigrees: application to Genetic Analysis Workshop 17 exome-sequencing SNP data. BMC Proc, 5 Suppl 9, S9.
  36. Lin WY, Camp NJ, Cannon-Albright LA, Allen-Brady K, Balasubramanian S, Reed MW, Hopper JL, Apicella C, Giles GG, Southey MC, Milne RL, Arias-Perez JI, Menendez-Rodriguez P, Benitez J, Grundmann M, Dubrowinskaja N, Park-Simon TW, Dork T, Garcia-Closas M, Figueroa J, Sherman M, Lissowska J, Easton DF, Dunning AM, Rajaraman P, Sigurdson AJ, Doody MM, Linet MS, Pharoah PD, Schmidt MK, Cox A (2011 Jul). A role for XRCC2 gene polymorphisms in breast cancer risk and survival. J Med Genet, 48(7), 477-84.
  37. Abo R, Knight S, Thomas A, Camp NJ (2011 Jan 01). Automated construction and testing of multi-locus gene-gene associations. Bioinformatics, 27(1), 134-6.
  38. Cai Z, Camp NJ, Cannon-Albright L, Thomas A (2011 Jun). Identification of regions of positive selection using Shared Genomic Segment analysis. Eur J Hum Genet, 19(6), 667-71.
  39. Knight S, Camp NJ (2011 Apr). Validity and power of association testing in family-based sampling designs: evidence for and against the common wisdom. Genet Epidemiol, 35(3), 174-81.
  40. Catalona WJ, Bailey-Wilson JE, Camp NJ, Chanock SJ, Cooney KA, Easton DF, Eeles RA, FitzGerald LM, Freedman ML, Gudmundsson J, Kittles RA, Margulies EH, McGuire BB, Ostrander EA, Rebbeck TR, Stanford JL, Thibodeau SN, Witte JS, Isaacs WB (2011 May 15). National Cancer Institute Prostate Cancer Genetics Workshop. Cancer Res, 71(10), 3442-6.
  41. Lanasa MC, Allgood SD, Slager SL, Dave SS, Love C, Marti GE, Kay NE, Hanson CA, Rabe KG, Achenbach SJ, Goldin LR, Camp NJ, Goodman BK, Vachon CM, Spector LG, Rassenti LZ, Leis JF, Gockerman JP, Strom SS, Call TG, Glenn M, Cerhan JR, Levesque MC, Weinberg JB, Caporaso NE (2011 Sep). Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL. Leukemia, 25(9), 1459-66.
  42. Slager SL, Rabe KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Lanasa MC, Spector LG, Rassenti LZ, Leis JF, Camp NJ, Glenn M, Kay NE, Cunningham JM, Hanson CA, Marti GE, Weinberg JB, Morrison VA, Link BK, Call TG, Caporaso NE, Cerhan JR (2011 Feb 10). Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood, 117(6), 1911-6.
  43. Abo R, Wong J, Thomas A, Camp NJ (2010 Dec 09). Haplotype association analyses in resources of mixed structure using Monte Carlo testing. BMC Bioinformatics, 11, 592.
  44. Christensen GB, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Xu J, Stanford JL, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Lange EM, Cooney KA, Tammela TL, Schleutker J, Paiss T, Maier C, Gronberg H, Wiklund F, Emanuelsson M, Farnham JM, Cannon-Albright LA, Camp NJ (2010 May 15). Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. Prostate, 70(7), 735-44.
  45. Conde L, Halperin E, Akers NK, Brown KM, Smedby KE, Rothman N, Nieters A, Slager SL, Brooks-Wilson A, Agana L, Riby J, Liu J, Adami HO, Darabi H, Hjalgrim H, Low HQ, Humphreys K, Melbye M, Chang ET, Glimelius B, Cozen W, Davis S, Hartge P, Morton LM, Schenk M, Wang SS, Armstrong B, Kricker A, Milliken S, Purdue MP, Vajdic CM, Boyle P, Lan Q, Zahm SH, Zhang Y, Zheng T, Becker N, Benavente Y, Boffetta P, Brennan P, Butterbach K, Cocco P, Foretova L, Maynadie M, de Sanjose S, Staines A, Spinelli JJ, Achenbach SJ, Call TG, Camp NJ, Glenn M, Caporaso NE, Cerhan JR, Cunningham JM, Goldin LR, Hanson CA, Kay NE, Lanasa MC, Leis JF, Marti GE, Rabe KG, Rassenti LZ, Spector LG, Strom SS, Vachon CM, Weinberg JB, Holly EA, Chanock S, Smith MT, Bracci PM, Skibola CF (2010 Aug). Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet, 42(8), 661-4.
  46. Coon H, Villalobos ME, Robison RJ, Camp NJ, Cannon DS, Allen-Brady K, Miller JS, McMahon WM (2010 Apr 08). Genome-wide linkage using the Social Responsiveness Scale in Utah autism pedigrees. Mol Autism, 1(1), 8.
  47. Anderson JL, Horne BD, Camp NJ, Muhlestein JB, Hopkins PN, Cannon-Albright LA, Mower CP, Park JJ, Clarke JL, Nicholas ZP, McKinney JT, Carlquist JF (2010 Aug). Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease. Am Heart J, 160(2), 250-256.e3.
  48. Goldin LR, Lanasa MC, Slager SL, Cerhan JR, Vachon CM, Strom SS, Camp NJ, Spector LG, Leis JF, Morrison VA, Glenn M, Rabe KG, Achenbach SJ, Algood SD, Abbasi F, Fontaine L, Yau M, Rassenti LZ, Kay NE, Call TG, Hanson CA, Weinberg JB, Marti GE, Caporaso NE (2010 Oct). Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families. Br J Haematol, 151(2), 152-8.
  49. Slager SL, Goldin LR, Strom SS, Lanasa MC, Spector LG, Rassenti L, Leis JF, Camp NJ, Kay NE, Vachon CM, Glenn M, Weinberg JB, Rabe KG, Cunningham JM, Achenbach SJ, Hanson CA, Marti GE, Call TG, Caporaso NE, Cerhan JR (2010 Apr). Genetic susceptibility variants for chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev, 19(4), 1098-102.
  50. Knight S, Coon H, Johnson M, Leppert MF, Camp NJ, McMahon WM, Tourette Syndrome Association International Consortium for Genetics (2010). Linkage analysis of Tourette Syndrome in a large Utah pedigree. Am J Med Genet B Neuropsychiatr Genet, 153B(2), 656-62.
  51. Curtin K, Iles MM, Camp NJ (2009 Jan). Identifying rarer genetic variants for common complex diseases: diseased versus neutral discovery panels. Ann Hum Genet, 73(1), 54-60.
  52. Christensen GB, Knight S, Camp NJ (2009 Nov). The sumLINK statistic for genetic linkage analysis in the presence of heterogeneity. Genet Epidemiol, 33(7), 628-36.
  53. Shephard ND, Abo R, Rigas SH, Frank B, Lin WY, Brock IW, Shippen A, Balasubramanian SP, Reed MW, Bartram CR, Meindl A, Schmutzler RK, Engel C, Burwinkel B, Cannon-Albright LA, Allen-Brady K, Camp NJ, Cox A (2009 Apr 01). A breast cancer risk haplotype in the caspase-8 gene. Cancer Res, 69(7), 2724-8.
  54. Camp NJ, Farnham JM, Wong J, Christensen GB, Thomas A, Cannon-Albright LA (2009 Apr). Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study. Cancer Epidemiol Biomarkers Prev, 18(4), 1290-4.
  55. Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, Dunning AM, Morrison J, Giles GG, Severi G, Baglietto L, English DR, Couch FJ, Olson JE, Wang X, Chang-Claude J, Flesch-Janys D, Abbas S, Salazar R, Mannermaa A, Kataja V, Kosma VM, Lindblom A, Margolin S, Heikkinen T, Kampjarvi K, Aaltonen K, Nevanlinna H, Bogdanova N, Coinac I, Schurmann P, Dork T, Bartram CR, Schmutzler RK, Tchatchou S, Burwinkel B, Brauch H, Torres D, Hamann U, Justenhoven C, Ribas G, Arias JI, Benitez J, Bojesen SE, Nordestgaard BG, Flyger HL, Peto J, Fletcher O, Johnson N, Dos Santos Silva I, Fasching PA, Beckmann MW, Strick R, Ekici AB, Broeks A, Schmidt MK, van Leeuwen FE, Vant Veer LJ, Southey MC, Hopper JL, Apicella C, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Kristensen V, Grenaker Alnaes G, Hunter DJ, Kraft P, Cox DG, Hankinson SE, Seynaeve C, Vreeswijk MP, Tollenaar RA, Devilee P, Chanock S, Lissowska J, Brinton L, Peplonska B, Czene K, Hall P, Li Y, Liu J, Balasubramanian S, Rafii S, Reed MW, Pooley KA, Conroy D, Baynes C, Kang D, Yoo KY, Noh DY, Ahn SH, Shen CY, Wang HC, Yu JC, Wu PE, Anton-Culver H, Ziogoas A, Egan K, Newcomb P, Titus-Ernstoff L, Trentham Dietz A, Sigurdson AJ, Alexander BH, Bhatti P, Allen-Brady K, Cannon-Albright LA, Wong J, Chenevix-Trench G, Spurdle AB, Beesley J, Pharoah PD, Easton DF, Garcia-Closas M (2009 May). Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev, 18(5), 1610-6.
  56. Allen-Brady K, Farnham JM, Camp NJ, Karlins E, Ostrander EA, Cannon-Albright LA (2009 May 28). No evidence of BRCA2 mutations in chromosome 13q-linked Utah high-risk prostate cancer pedigrees. BMC Res Notes, 2, 94.
  57. Cao TM, Lazzeroni LC, Tsai S, Pang WW, Kao A, Camp NJ, Thomas A, Shizuru JA (2009 Jul 01). Identification of a major susceptibility locus for lethal graft-versus-host disease in MHC-matched mice. J Immunol, 183(1), 462-9.
  58. Curtin K, Lin WY, George R, Katory M, Shorto J, Cannon-Albright LA, Smith G, Bishop DT, Cox A, Camp NJ (2009 Sep). Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis. Cancer Epidemiol Biomarkers Prev, 18(9), 2476-84.
  59. Knight S, Abo RP, Wong J, Thomas A, Camp NJ (2009). Pedigree association: assigning individual weights to pedigree members for genetic association analysis. BMC Proc, 3(Suppl 7), S121.
  60. Piccolo SR, Abo RP, Allen-Brady K, Camp NJ, Knight S, Anderson JL, Horne BD (2009). Evaluation of genetic risk scores for lipid levels using genome-wide markers in the Framingham Heart Study. BMC Proc, 3(Suppl 7), S46.
  61. Teerlink CC, Camp NJ, Bansal A, Crapo R, Hughes D, Kort E, Rowe K, Cannon-Albright LA (2009 May). Significant evidence for linkage to chromosome 5q13 in a genome-wide scan for asthma in an extended pedigree resource. Eur J Hum Genet, 17(5), 636-43.
  62. Curtin K, Lin WY, George R, Katory M, Shorto J, Cannon-Albright LA, Bishop DT, Cox A, Camp NJ, Colorectal Cancer Study Group (2009). Meta association of colorectal cancer confirms risk alleles at 8q24 and 18q21. Cancer Epidemiol Biomarkers Prev, 18(2), 616-21.
  63. Camp NJ, Werner TL, Cannon-Albright LA (2008 Oct 16). Familial myeloma. N Engl J Med, 359(16), 1734-5; author reply 1735.
  64. Anderson JL, Horne BD, Kolek MJ, Muhlestein JB, Mower CP, Park JJ, May HT, Camp NJ, Carlquist JF (2008 Dec). Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utility. Am Heart J, 156(6), 1155-1162.e2.
  65. Abo R, Knight S, Wong J, Cox A, Camp NJ (2008 Sep 15). hapConstructor: automatic construction and testing of haplotypes in a Monte Carlo framework. Bioinformatics, 24(18), 2105-7.
  66. Rausch T, Thomas A, Camp NJ, Cannon-Albright LA, Facelli JC (2008 Jul). A parallel genetic algorithm to discover patterns in genetic markers that indicate predisposition to multifactorial disease. Comput Biol Med, 38(7), 826-36.
  67. Gibbs D, Yang Z, Constantine R, Ma X, Camp NJ, Yang X, Chen H, Jorgenson A, Hau V, Dewan A, Zeng J, Harmon J, Buehler J, Brand JM, Hoh J, Cameron DJ, Dixit M, Tong Z, Zhang K (2008 Feb). Further mapping of 10q26 supports strong association of HTRA1 polymorphisms with age-related macular degeneration. Vision Res, 48(5), 685-9.
  68. Cameron DJ, Yang Z, Tong Z, Zhao Y, Praggastis A, Brinton E, Harmon J, Chen Y, Pearson E, Bernstein PS, Brinton G, Li X, Jorgensen A, Schneider S, Gibbs D, Chen H, Wang C, Howes K, Camp NJ, Zhang K (2008). 10q26 is associated with increased risk of age-related macular degeneration in the Utah population. Adv Exp Med Biol, 613, 253-8.
  69. Thomas A, Camp NJ, Farnham JM, Allen-Brady K, Cannon-Albright LA (2008 Epub 2007 Dec 18). Shared Genomic Segment Analysis. Mapping Disease Predisposition Genes in Extended Pedigrees Using SNP Genotype Assays. Ann Hum Genet, 72(Pt 2), 279-87.
  70. Curtin K, Wong J, Allen-Brady K, Camp NJ (2007). Meta genetic association of Rheumatoid Arthritis and PTPN22 using PedGenie 2.0. BMC Proc, 1(1), S12.
  71. Allen-Brady K, Horne BD, Malhotra A, Teerlink C, Camp NJ, Thomas A (2007). Analysis of high-density single-nucleotide polymorphism data: three novel methods that control for linkage disequilibrium between markers in a linkage analysis. BMC Proc, 1 Suppl 1, S160.
  72. Christensen GB, Cannon-Albright LA, Thomas A, Camp NJ (2007). Extracting disease risk profiles from expression data for linkage analysis: application to prostate cancer. BMC Proc, 1 Suppl 1, S82.
  73. Christensen GB, Camp NJ, Farnham JM, Cannon-Albright LA (2007 May 1). Genome-wide linkage analysis for aggressive prostate cancer in Utah high-risk pedigrees. Prostate, 67(6), 605-13.
  74. Curtin K, Wong J, Allen-Brady K, Camp NJ (2007 Nov 15). PedGenie: meta genetic association testing in mixed family and case-control designs. BMC Bioinformatics, 8(1), 448.
  75. Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Xu J, Stanford JL, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Lange EM, Cooney KA, Tammela TL, Schleutker J, Paiss T, Maier C, Gronberg H, Wiklund F, Emanuelsson M, Isaacs WB (2007 Jun 01). Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet, 16(11), 1271-8.
  76. Horne BD, Camp NJ, Anderson JL, Mower CP, Clarke JL, Kolek MJ, Carlquist JF (2007 May 22). Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease. J Am Coll Cardiol, 49(20), 2053-60.
  77. Zintzaras E, Kitsios G, Kent D, Camp NJ, Atwood L, Hopkins PN, Hunt SC (2007 Sep). Genome-wide scans meta-analysis for pulse pressure. Hypertension, 50(3), 557-64.
  78. Camp NJ, Farnham JM, Allen-Brady K, Cannon-Albright LA (2007 Sep 15). Statistical recombinant mapping in extended high-risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb. Prostate, 67(13), 1456-64.
  79. Horne BD, Camp NJ, Carlquist JF, Muhlestein JB, Kolek MJ, Nicholas ZP, Anderson JL (2007 Oct). Multiple-polymorphism associations of 7 matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease. Am Heart J, 154(4), 751-8.
  80. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, Chen H, Zhao Y, Pearson E, Li X, Chien J, Dewan A, Harmon J, Bernstein PS, Shridhar V, Zabriskie NA, Hoh J, Howes K, Zhang K (2006 Nov 10). A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science, 314(5801), 992-3.
  81. Thomas A, Camp NJ (2006 Mar 15). Maximum likelihood estimates of allele frequencies and error rates from samples of related individuals by gene counting. Bioinformatics, 22(6), 771-2.
  82. Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Thibodeau SN, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Badzioch M, Bishop DT, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Guy M, Hsieh CL, Halpern J, Balise RR, Oakley-Girvan I, Whittemore AS, Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Friedrichsen DM, Deutsch K, Kolb S, Janer M, Hood L, Ostrander EA, Stanford JL, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Lange EM, Ho LA, Beebe-Dimmer JL, Wood DP, Cooney KA, Seminara D, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TL, Bailey-Wilson J, Schleutker J, Maier C, Herkommer K, Hoegel JJ, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Gronberg H, Camp NJ, Farnham J, Cannon-Albright LA, Catalona WJ, Suarez BK, Roehl KA (2006 Nov). Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet, 120(4), 471-85.
  83. Horne BD, Carlquist JF, Cannon-Albright LA, Muhlestein JB, McKinney JT, Kolek MJ, Clarke JL, Anderson JL, Camp NJ (2006 Jul). High-resolution characterization of linkage disequilibrium structure and selection of tagging single nucleotide polymorphisms: application to the cholesteryl ester transfer protein gene. Ann Hum Genet, 70(Pt 4), 524-34.
  84. Allen-Brady K, Cannon-Albright LA, Neuhausen SL, Camp NJ (2006 Jul). A role for XRCC4 in age at diagnosis and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 15(7), 1306-10.
  85. Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA (2006 Aug). Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database. Am Heart J, 152(2), 305-11.
  86. Camp NJ, Farnham JM, Cannon-Albright LA (2006 Oct 15). Localization of a prostate cancer predisposition gene to an 880-kb region on chromosome 22q12.3 in Utah high-risk pedigrees. Cancer Res, 66(20), 10205-12.
  87. Allen-Brady K, Wong J, Camp NJ (2006 Apr 18). PedGenie: an analysis approach for genetic association testing in extended pedigrees and genealogies of arbitrary size. BMC Bioinformatics, 7, 209.
  88. Cannon-Albright LA, Schwab A, Camp NJ, Farnham JM, Thomas A (2005). Population-based Risk Assessment for Other Cancers in Relatives of Hereditary Prostate Cancer (HPC) Cases. Prostate, 64(4), 347-55.
  89. Coon H, Matsunami N, Stevens J, Miller J, Pingree C, Camp NJ, Thomas A, Krasny L, Lainhart J, Leppert MF, McMahon W (2005). Evidence for linkage on chromosome 3q25-27 in a large autism extended pedigree. Hum Hered, 60(4), 220-6.
  90. Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Bishop T, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Hsieh CL, Halpern J, Balise RN, Oakley-Girvan I, Whittemore AS, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Thibodeau SN, McDonnell SK, Cunningham JM, Zarfas KE, Hebbring S, Schaid DJ, Friedrichsen DM, Deutsch K, Kolb S, Badzioch M, Jarvik GP, Janer M, Hood L, Ostrander EA, Stanford JL, Lange EM, Beebe-Dimmer JL, Mohai CE, Cooney KA, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TLj, Bailey-Wilson J, Schleutker J, Maier C, Herkommer K, Hoegel JJ, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Gronberg H, Camp NJ, Farnham J, Cannon-Albright LA, Seminara D (2005 Aug). A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet, 77(2), 219-29.
  91. Cannon-Albright LA, Farnham JM, Thomas A, Camp NJ (2005 Sep 01). Identification and study of Utah pseudo-isolate populations-prospects for gene identification. Am J Med Genet A, 137A(3), 269-75.
  92. Camp NJ, Lowry MR, Richards RL, Plenk AM, Carter C, Hensel CH, Abkevich V, Skolnick MH, Shattuck D, Rowe KG, Hughes DC, Cannon-Albright LA (2005 May 05). Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders. Am J Med Genet B Neuropsychiatr Genet, 135B(1), 85-93.
  93. Berthelemy-Okazaki N, Zhao Y, Yang Z, Camp NJ, Farnham J, Parker D, Tsuruda J, Macdonald J, Zhang K, Cannon-Albright LA (2005 Jun). Examination of ELN as a candidate gene in the Utah intracranial aneurysm pedigrees. Stroke, 36(6), 1283-4.
  94. Allen-Brady K, Camp NJ, Ward JH, Cannon-Albright LA (2005 Nov 20). Lobular breast cancer: excess familiality observed in the Utah Population Database. Int J Cancer, 117(4), 655-61.
  95. Camp NJ, Cox A, di Giovine FS, McCabe D, Rich W, Duff GW (2005 Sep). Evidence of a pharmacogenomic response to interleukin-l receptor antagonist in rheumatoid arthritis. Genes Immun, 6(6), 467-71.
  96. Camp NJ, Farnham JM, Cannon Albright LA (2005 Dec 01). Genomic search for prostate cancer predisposition loci in Utah pedigrees. Prostate, 65(4), 365-74.
  97. Allen-Brady K, Camp NJ (2005 Aug 09). Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in five DNA repair genes. BMC Cancer, 5, 99.
  98. Farnham JM, Camp NJ, Swensen J, Tavtigian SV, Albright LA (2005 Feb). Confirmation of the HPCX prostate cancer predisposition locus in large Utah prostate cancer pedigrees. Hum Genet, 116(3), 179-85.
  99. Camp NJ, Swensen J, Horne BD, Farnham JM, Thomas A, Cannon-Albright LA, Tavtigian SV (2005 Apr). Characterization of linkage disequilibrium structure, mutation history, and tagging SNPs, and their use in association analyses: ELAC2 and familial early-onset prostate cancer. Genet Epidemiol, 28(3), 232-43.
  100. Horne BD, Anderson JL, Carlquist JF, Muhlestein JB, Renlund DG, Bair TL, Pearson RR, Camp NJ (2005 Mar). Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints. Ann Hum Genet, 69(Pt 2), 176-86.
  101. Schaid DJ, Chang BL, the ICPCG (2004). Description of the international consortium for prostate cancer genetics, and failure to replicate linkage of hereditay prostate cancer to 20q13. Prostate, 63(3), 276-90.
  102. Farnham JM, Camp NJ, Neuhausen SL, Tsuruda J, Parker D, MacDonald J, Cannon-Albright LA (2004 Feb). Confirmation of chromosome 7q11 locus for predisposition to intracranial aneurysm. Hum Genet, 114(3), 250-5.
  103. Horne BD, Camp NJ (2004 Jan). Principal component analysis for selection of optimal SNP-sets that capture intragenic genetic variation. Genet Epidemiol, 26(1), 11-21.
  104. Carter MJ, Jones S, Camp NJ, Cox A, Mee J, Warren B, Duff GW, Lobo AJ, di Giovine FS (2004 Jan). Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis. Genes Immun, 5(1), 8-15.
  105. Thomas A, Camp NJ (2004 Jun). Graphical modeling of the joint distribution of alleles at associated loci. Am J Hum Genet, 74(6), 1088-101.
  106. Hunt SC, Coon H, Hasstedt SJ, Cawthon RM, Camp NJ, Wu LL, Hopkins PN (2004 Jun). Linkage of serum creatinine and glomerular filtration rate to chromosome 2 in Utah pedigrees. Am J Hypertens, 17(6), 511-5.
  107. Hasstedt SJ, Camp NJ, Hopkins PN, Coon H, McKinney JT, Cawthon RM, Hunt SC (2004 Dec). Model-fitting and linkage analysis of sodium-lithium countertransport. Eur J Hum Genet, 12(12), 1055-61.
  108. Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA (2004 Nov 09). Evidence for a heritable component in death resulting from aortic and mitral valve diseases. Circulation, 110(19), 3143-8.
  109. Camp NJ, Hopkins PN, Hasstedt SJ, Coon H, Malhotra A, Cawthon RM, Hunt SC (2003 Sep). Genome-wide multipoint parametric linkage analysis of pulse pressure in large, extended utah pedigrees. Hypertension, 42(3), 322-8.
  110. Cannon Albright LA, Camp NJ, Farnham JM, MacDonald J, Abtin K, Rowe KG (2003 Oct). A genealogical assessment of heritable predisposition to aneurysms. J Neurosurg, 99(4), 637-43.
  111. Abkevich V, Camp NJ, Hensel CH, Neff CD, Russell DL, Hughes DC, Plenk AM, Lowry MR, Richards RL, Carter C, Frech GC, Stone S, Rowe K, Chau CA, Cortado K, Hunt A, Luce K, ONeil G, Poarch J, Potter J, Poulsen GH, Saxton H, Bernat-Sestak M, Thompson V, Gutin A, Skolnick MH, Shattuck D, Cannon-Albright L (2003 Dec). Predisposition locus for major depression at chromosome 12q22-12q23.2. Am J Hum Genet, 73(6), 1271-81.
  112. Goldin LR, Camp NJ, Keen KJ, Martin LJ, Moslehi R, Ghosh S, North KE, Wyszynski DF, Blacker D (2003). Analysis of metabolic syndrome phenotypes in Framingham Heart Study families from Genetic Analysis Workshop 13. Genet Epidemiol, 25 Suppl 1, S78-89.
  113. Allen-Brady K, Farnham JM, Weiler J, Camp NJ (2003 Dec 31). A cautionary note on the appropriateness of using a linkage resource for an association study. BMC Genet, 4 Suppl 1, S89.
  114. Horne BD, Malhotra A, Camp NJ (2003 Dec 31). Comparison of linkage analysis methods for genome-wide scanning of extended pedigrees, with application to the TG/HDL-C ratio in the Framingham Heart Study. BMC Genet, 4 Suppl 1, S93.
  115. Neuhausen SL, Weizman Z, Camp NJ, Elbedour K, Sheffield VC, Zone JJ, Carmi R (2002 Jun). HLA DQA1-DQB1 genotypes in Bedouin families with celiac disease. Hum Immunol, 63(6), 502-7.
  116. Neuhausen SL, Feolo M, Camp NJ, Farnham J, Book L, Zone JJ (2002 Jul 22). Genome-wide linkage analysis for celiac disease in North American families. Am J Med Genet, 111(1), 1-9.
  117. Ray KK, Camp NJ, Bennett CE, Francis SE, Crossman DC (2002 Sep). Genetic variation at the interleukin-1 locus is a determinant of changes in soluble endothelial factors in patients with acute coronary syndromes. Clin Sci (Lond), 103(3), 303-10.
  118. Hunt SC, Hasstedt SJ, Coon H, Camp NJ, Cawthon RM, Wu LL, Hopkins PN (2002 Oct). Linkage of creatinine clearance to chromosome 10 in Utah pedigrees replicates a locus for end-stage renal disease in humans and renal failure in the fawn-hooded rat. Kidney Int, 62(4), 1143-8.
  119. Camp NJ, Slattery ML (2002 Nov). Classification tree analysis: a statistical tool to investigate risk factor interactions with an example for colon cancer (United States). Cancer Causes Control, 13(9), 813-23.
  120. Fujiwara H, Emi M, Nagai H, Nishimura T, Konishi N, Kubota Y, Ichikawa T, Takahashi S, Shuin T, Habuchi T, Ogawa O, Inoue K, Skolnick MH, Swensen J, Camp NJ, Tavtigian SV (2002). Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series. J Hum Genet, 47(12), 641-8.
  121. Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J, Cannon-Albright LA (2001 Feb). A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet, 27(2), 172-80.
  122. Francis SE, Camp NJ, Burton AJ, Dewberry RM, Gunn J, Stephens-Lloyd A, Cumberland DC, Gershlick A, Crossman DC (2001 Sep). Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty. Heart, 86(3), 336-40.
  123. Camp NJ, Neuhausen SL, Tiobech J, Polloi A, Coon H, Myles-Worsley M (2001 Dec). Genomewide multipoint linkage analysis of seven extended Palauan pedigrees with schizophrenia, by a Markov-chain Monte Carlo method. Am J Hum Genet, 69(6), 1278-89.
  124. Camp NJ, Gutin A, Abkevich V, Farnham JM, Cannon-Albright L, Thomas A (2001). A new nonparametric linkage statistic for mapping both qualitative and quantitative trait loci. Genet Epidemiol, 21 Suppl 1, S461-6.
  125. Abkevich V, Camp NJ, Gutin A, Farnham JM, Cannon-Albright L, Thomas A (2001). A robust multipoint linkage statistic (tlod) for mapping complex trait loci. Genet Epidemiol, 21 Suppl 1, S492-7.
  126. Gutin A, Abkevich V, Camp NJ, Farnham JM, Cannon-Albright L, Thomas A (2001). Allelic association in large pedigrees. Genet Epidemiol, 21 Suppl 1, S571-5.
  127. Camp NJ, Farnham JM (2001 Nov). Correcting for multiple analyses in genomewide linkage studies. Ann Hum Genet, 65(Pt 6), 577-82.
  128. Carter MJ, di Giovine FS, Jones S, Mee J, Camp NJ, Lobo AJ, Duff GW (2001 Apr). Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians. Gut, 48(4), 461-7.
  129. Iacoviello L, Donati MB, Gattone M, Crossman DC, Francis SE, Camp NJ, Dewberry RM, Gunn J, Cumberland DC, Duff, GW, Syrris P, Carter ND, Jeffery S, Kaski JC (2000). Possible different involvement of interleukin-1 receptor antagonist gene polymorphism in coronary single vessel disease and myocardial infarction response. Circulation, 101e, 193.
  130. Read RC, Camp NJ, di Giovine FS, Borrow R, Kaczmarski EB, Chaudhary AG, Fox AJ, Duff GW (2000 Nov). An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J Infect Dis, 182(5), 1557-60.
  131. Camp NJ, Cannings C, Sheehan NA (1999). The number of genotypic assignments on a genealogy II Further results for linear systems. IMA J Math Appl Med Biol, 16, 213-36.
  132. Camp NJ, Bansal A (1999). A low density genome-wide search for loci involved in alcohol dependence using the transmission/disequilibrium test, sib-TDT, and two combined tests. Genet Epidemiol, 17 Suppl 1, S85-90.
  133. Gordon MA, Oppenheim E, Camp NJ, di Giovine FS, Duff GW, Gleeson D (1999 Aug). Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region. J Hepatol, 31(2), 242-7.
  134. Cox A, Camp NJ, Cannings C, di Giovine FS, Dale M, Worthington J, John S, Ollier WE, Silman AJ, Duff GW (1999 Sep). Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis. Hum Mol Genet, 8(9), 1707-13.
  135. Tazi Ahnini R, Camp NJ, Cork MJ, Mee JB, Keohane SG, Duff GW, di Giovine FS (1999 Jun). Novel genetic association between the corneodesmosin (MHC S) gene and susceptibility to psoriasis. Hum Mol Genet, 8(6), 1135-40.
  136. Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND, Jeffery S, Kaski JC, Cumberland DC, Duff GW, Crossman DC (1999 Feb 23). Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation, 99(7), 861-6.
  137. Cox A, Camp NJ, Nicklin MJ, di Giovine FS, Duff GW (1998 May). An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. Am J Hum Genet, 62(5), 1180-8.
  138. Camp NJ, Bansal A (1997). The effect of selective sampling on mapping quantitative trait loci. Genet Epidemiol, 14(6), 767-72.
  139. Camp NJ (1997 Dec). Genomewide transmission/disequilibrium testing--consideration of the genotypic relative risks at disease loci. Am J Hum Genet, 61(6), 1424-30.
  140. Camp N, Cannings C, Sheehan N (1994). The number of genotypic assignments on a genealogy. I. The method and simple examples. IMA J Math Appl Med Biol, 11(2), 95-106.

Review

  1. Camp NJ, Cannon-Albright LA (2005 Mar). Dissecting the genetic etiology of major depressive disorder using linkage analysis. [Review]. Trends Mol Med, 11(3), 138-44.

Edited Book

  1. Camp NJ, Cox A (Eds.) (2002). Quantitative Trait Loci: Methods and Protocols. Humana Press.

Book Chapter

  1. Allen-Brady K, Camp NJ (). Genetic Distance and Markers used in Linkage Mapping. In Teare D (Ed.), A Primer in Genetic Epidemiology (713, pp. 43-53). Humana Press.
  2. Curtin K, Camp NJ (). Fine-scale Structure of the Genome and Markers used in Association Mapping. In Teare D (Ed.), A Primer in Genetic Epidemiology (713, pp. 71-88). Humana Press.
  3. Camp NJ, Bansal A (). Complex multifactorial genetic diseases (version 2.0). In Encyclopedia of Life Sciences. Macmillan Reference Ltd.
  4. di Giovine FS, Camp NJ, Cox A, Chaudhary AG, Sorrell JA, Crane A, Duff GW (). Detection and Population Analysis of IL-1 and TNF gene Polymorphisms. In Balkwill F (Ed.), Cytokine Molecular Biology (pp. 21-446). Oxford: Oxford University Press.
  5. Camp NJ, Bansal A (). Complex/Multifactorial Diseases. In Encyclopedia of Life Sciences. MacmillanReference Ltd.

Conference Proceedings

  1. Piccolo SR, Camp N, Frey LJ (2008 Nov 06). Polygenic model for predicting breast cancer risk via genome-wide polymorphisms. AMIA Annu Symp Proc, United States, 1094.
  2. Abo R, Knight S, Camp NJ (2008). Associated haplotypes in the Framingham 500K genomewide dataset. Genetic Analysis Workshop, September 17th - 19th, 2008, St. Louis, MO.
  3. Piccolo SR, Allen-Brady K, Camp NJ, Knight s, anderson JL, Horne BD (In Press). Genome-wide Association Study in the Framingham Heart Study using 500,000 SNPs: Association with Lipid Levels and Creation of Genetic Risk Scores. Genetic Analysis Workshop 16, St Louis Missouri, September 17th -20th, 2008.
  4. Knight S, Abo RP, Wong J, Camp NJ (2008). Weighting of individuals from pedigrees in genetic association analysis. International Genetic Epidemiology Society, September 15-16, 2008, St Louis, MO; Genetic Analysis Workshop, September 17th-19th, 2008, St Louis, MO.
  5. Curtin K, Wong J, Allen-Brady K, Camp NJ (2007). Meta-genetic association of rheumatoid arthritis and PTPN22 using PedGenie 2.1. BMC Proc, England, 1 Suppl 1, S12.
  6. Christensen GB, Cannon-Albright LA, Thomas A, Camp NJ (2007). Extracting disease risk profiles from expression data for linkage analysis: Application to Prostate Cancer. Genetic Analysis Meeting 15, Tampa Bay, FL: BMC Proceedinngs, 1(Suppl 1), S82.
  7. Neuhausen SL, Csokay B, Farnham J, Camp NJ, Nathanson K, Rebbeck T, Weber B, Tavtigian S, Cannon-Albright LA (2002). Association of Two HPC2/ELAC2 Missense Variants with Risk of Breast Cancer. Era of Hope, Department of Defence Breast Cancer Research Program Meeting, In Proceedings of Era of Hope, Department of Defense Breast Cancer Research Program Meeting, 26-35.
  8. Camp NJ, Cannings C, Knowler WC (1996). The Gibbs sampler: an efficient method of segregation analysis of NIDDM in the Pima. Proc. European Mathematical Genetics, 43-52.

Letter

  1. Hebbring SJ, Slager SL, Epperla N, Mazza JJ, Ye Z, Zhou Z, Achenbach SJ, Vasco DA, Call TG, Rabe KG, Kay NE, Caporaso NE, Lanasa MC, Camp NJ, Strom SS, Goldin LR, Cerhan JR, Brilliant MH, Schrodi SJ (2013 Jan 03). Genetic evidence of PTPN22 effects on chronic lymphocytic leukemia [Letter to the editor]. Blood, 121(1), 237-8.
  2. Camp NJ, Werner TL, Cannon-Albright LA (2008). Response to Lynch et al 'Familial Myeloma' [Letter to the editor]. N Engl J Med, 359(16), 1734-5.
  3. Camp NJ, Tavtigian SV (2002 Dec). Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer [Letter to the editor]. Am J Hum Genet, 71(6), 1475-8.
  4. Camp NJ (1999 May). Genomewide Transmission/Disequilibrium testing: a correction [Letter to the editor]. Am J Hum Genet, 64(5), 1485-7.

Abstract

  1. Waller RG, Darlington TM, Wei X, Madsen MJ, Thomas A, Curtin K, Coon H, Rajamanickam V, Musinsky J, Jayabalan D, Atanackovic D, Rajkumar SV, Kumar S, Slager S, Middha M, Galia P, Demangel D, Salama M, Joseph V, McKay J, Offit K, Klein RJ, Lipkin SM, Dumontet C, Vachon CM, Camp NJ (). Novel pedigree analysis implicates DNA repair and chromatin remodeling in multiple myeloma risk. PLoS Genet. 2018 Feb 1;14(2):e1007111. doi: 10.1371/journal.pgen.1007111. eCollection
    2018 Feb. PubMed PMID: 29389935
    [Abstract].
  2. Wei X, Calvo-Vidal MN, Chen S, Wu G, Revuelta MV, Sun J, Zhang J, Walsh MF, Nichols KE, Joseph V, Snyder C, Vachon CM, McKay JD, Wang SP, Jayabalan DS, Jacobs LM, Becirovic D, Waller RG, Artomov M, Viale A, Patel J, Phillip JM, Chen-Kiang S, Curtin K, Salama M, Atanackovic D, Niesvizky R, Landgren O, Slager SL, Godley LA, Churpek J, Garber JE, Anderson KC, Daly MJ, Roeder RG, Dumontet C, Lynch HT, Mullighan CG, Camp NJ, Offit K, Klein RJ, Yu H, Cerchietti L, Lipkin SM (). Germline mutations in lysine specific demethylase 1 (LSD1/KDM1A) confer susceptibility to multiple myeloma. Cancer Res. 2018 Mar 20. pii: canres.1900.2017. doi: 10.1158/0008-5472.CAN-17-1900. [Epub ahead of print] PubMed PMID: 29559475 [Abstract].
  3. Madsen MJ, Knight S, Sweeney C, Factor RE, Salama ME, Stijleman IJ, Rajamanickam V, Welm BE, Arunachalam S, Jones B, Rachamadugu R, Rowe K, Cessna M, Thomas A, Kushi LH, Caan B, Bernard PS, Camp NJ (). Reparameterization of PAM50 expression identifies novel breast tumor dimensions and leads to discovery of a genomewide significant breast cancer locus at 12q15. Cancer Epidemiol Biomarkers Prev. 2018 Apr 12. pii: cebp.0887.2017. doi: 10.1158/1055-9965.EPI-17-0887. [Epub
    ahead of print] PubMed PMID: 29650789
    [Abstract].
  4. Wang SS, Carrington M, Berndt S, Slager SL, Bracci PM, Voutsinas J, Cerhan J, Ekstrm Smedby K, Hjalgrim H, Joseph V, Morton L, Vermeulen R, Paltiel O, Vajdic C, Linet M, Nieters A, de Sanjos S, Cozen W, Brown E, Turner J, Spinelli J, Zheng T, Birmann B, Flowers C, Becker N, Holly E, Kane E, Weisenburger D, Maynadie M, Cocco P, Albanes D, Weinstein S, Teras L, Diver W, Lax S, Travis R, Kaaks R, Riboli E, Benavente Y, Brennan P, McKay J, Delfau-Larue MH, Link B, Magnani C, Ennas M, Latte G, Feldman A, Wong Doo N, Giles G, Southey M, Milne R, Offit K, Muskinsky J, Arslan A, Purdue M, Adami H-O, Melbye M, Glimelius B, Conde L, Camp NJ, Glenn M, Curtin K, Clavel J, Monnereau A, Cox D, Ghesquires H, Salles G, Bofetta P, Foretova L, Staines A, Davis S, Severson R, Lang Q, Brooks-Wilson A, Smith M, Roman E, Kricker A, Zhang Y, Kraft P, Chanock S, Rothman N, Hartge P, Skibola C (). The role of HLA class I and II diversity in the etiologic heterogeneity of non-Hodgkin lymphoma subtypes, Cancer Res. 2018 In Press PMID: 29735552 [Abstract].
  5. Kleinstern G, Camp NJ, Goldin LR, Vachon CM, Vajdic CM, de Sanjose S, Weinberg JB, Benavente Y, Casabonne D, Liebow M, Nieters A, Hjalgrim H, Melbye M, Glimelius B, Adami HO, Boffetta P, Brennan P, Maynadie M, McKay J, Cocco PL, Shanafelt TD, Call TG, Norman A, Hanson C, Robinson D, Chaffee KG, Brooks-Wilson AR, Monnereau A, Clavel J, Glenn M, Curtin K, Conde L, Bracci PM, Morton LM, Cozen W, Severson RK, Chanock SJ, Spinelli JJ, Johnston JB, Rothman N, Skibola CF, Leis JF, Kay NE, Smedby KE, Berndt SI, Cerhan JR, Caporaso N, Slager SL (). Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis. Blood. 2018 Apr 19. pii: blood-2017-11-814608. doi: 10.1182/blood-2017-11-814608. [Epub ahead of print]PubMed PMID: 29674426 [Abstract].
  6. Lipkin S, Wei X, Yu H, Joseph V, Snyder C, Villano D, Daly M, Altshuler D, Camp NJ, Vachon C, Slager S, Godley L, Niesvizky R, Chen-Kiang S, Lynch HT, Offit K (). Whole Exome and Genome Sequencing to Identify Familial Multiple Myeloma and Other B Cell Malignancy Risk Genes [Abstract]. American College of Medical Genetics Meeting, Salt Lake City, UT, March 24-28, 2015.
  7. Curtin K, Neumayer L, Morgan M, Stein M, Camp NJ, Smith K, Rowe K, Buys S (). Familial risk of breast density in extended Utah pedigrees [Abstract]. San Antonio Breast Cancer Symposium, San Antonio, TX, December 2014.
  8. Heikal N, Pavlov I, Salama M, Delgado J, Camp NJ, Halwani A (). Soluble CD30 levels in Chronic Lymphocytic Leukemia / Small Lymphocytic lymphoma patients [Abstract]. American Society of Clinical Pathology, Tampa, FL, October 2014.
  9. Glenn MJ, Waller RG, Camp NJ (). Exome sequencing in a family with B-cell Non-hodgkin Lymphoma and autoimmune disease uncovers potential germline risk-alleles [Abstract]. Blood, 124(21), 5629.
  10. Lipkin S, Wei X, Yu H, Schrader KA, Vijai J, Snyder C, Corines M, Villano D, Daly M, Altshuler D, Camp NJ, Godley L, Niesvizky R, Chen-Kiang S, Lynch HT, Offit K (). Whole exome and genome sequencing to identify familial B cell malignancy risk genes [Abstract]. American College of Medical Genetics: Annual Clinical Genetics Meeting, Nashville, TN, March 25-29.
  11. Coon H, Darlington T, Pimentel R, Smith KR, Huff C, Hu H, Jerominski L, Hansen J, Klein M, Callor WB, Byrd J, Bakian A, Crowell S, McMahon WM, Rajamanickam V, Camp NJ, McGlade E, Yurgelun-Todd D, Grey T, Gray D (). Genetic risk factors in two Utah pedigrees at high risk for suicide [Abstract]. American Society of Human Genetics, Boston, MA, October 22-26.
  12. Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z, Cozen W, Monnereau A, Kelly RS, De Sanjose, Linet MS, Riboli E, Vineis P, Hjalgrim H, Cerhan JR, Chanock SJ, Rothman N, Slager SL (). Meta-analysis of genome-wide association studies identifies multiple loci associated with chronic lymphocytic leukemia [Abstract]. American Association for Cancer Research, Washington, DC, April 6-10.
  13. Lin WY, Brock IW, Connley D, Cramp H, Slate J, Camp NJ, Reed MWR, Cox A (). Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer [Abstract]. Yorkshire Cancer Research Annual Scientific Meeting, North Yorkshire, UK, June 26.
  14. Rigas SH, Camp NJ, Cox A (). Identification of regulatory DNA variants in Apoptosis genes associated with breast cancer risk [Abstract]. Yorkshire Cancer Research Annual Scientific Meeting, North Yorkshire, UK, June 26.
  15. Buxbaum JD, Daly MJ, Devlin B, Lehner T, Roeder K, State MW, Autism Sequencing Consortium (). The autism sequencing consortium: large-scale, high-throughput sequencing in autism spectrum disorders [Abstract]. Neuron, 76(6), 1052-6.
  16. Bigelow A, Meyer M, Camp NJ (). Prioritization of next-generation sequencing variants using data visualization [Abstract]. American Society of Human Genetics, San Francisco, CA, November 6-10.
  17. Bigelow A, Meyer M, Camp NJ (). CompreheNGSive: A tool for exploring next-gen sequence variants [Abstract]. BIOVIS: 2nd IEEE Symposium on Biological Data Visualization, Seattle, WA, October 14-15.
  18. Curtin K, Wong J, Camp NJ (). Gene-environment association testing in pedigrees and mixed study designs [Abstract]. International Genetic Epidemiology Society, Stevenson, WA, October 18-20.
  19. Bigelow A, Meyer M, Camp NJ (). CompreheNGSive - A visualization tool for prioritizing variants from next generation sequence data [Abstract]. International Genetic Epidemiology Society, Stevenson, WA, October 18-20.
  20. Knight S, Bigelow A, Piccolo S, Meyer M, Horne BD, Camp NJ (). Using a visualization tool, compreheNGSive, to identify and prioritize variants from next generation sequence data [Abstract]. Genetic Analysis Workshop 18, Stevenson, WA, October 13-17.
  21. Birmann B, Andreotti G, De Roos A, Spinelli J, Cozen W, Camp NJ, Moysich K, Chiu B, Boffetta P, Benhaim-Luzon V, Brennan P, de Sanjose S, Costas Caudet L, Costantini AS, Cocco P, Becker N, Foretova L, Maynadie M, Nieters A, Staines A, Milliken K, Weisenburger D, Baris D, Purdue M (). A pooled analysis of lifestyle factors and risk of MM in the International Multiple Myeloma Consortium [Abstract]. International Myeloma Workshop, Paris, France, May 3-6.
  22. Rigas SH, Elliot G, Parry M, Brock I, Abo R, Knight S, Burghel G, Lin W-Y, Reed MW, Camp NJ, Cox A (). Association of the TNFRSF10A and TNFRSF10B gene region on chromosome 8 with breast cancer risk [Abstract]. Yorkshire Cancer Research Annual Meeting, UK, June.
  23. Lin W-Y, Burghel G, Connley D, Brock IW, Parry M, Rigas SH, Cannon-Albright L, Liu X, Ashelford K, Darby A, Camp NJ, Cox A (). Next generation sequencing of 2.6 Mbases of genomic DNA using the SOLID platform to identify breast-cancer related variants [Abstract]. Yorkshire Cancer Research Annual Meeting, UK, June.
  24. Rigas SH, Elliott G, Parry M, Brock I, Abo R, Knight S, Burghel G, Lin W-Y, Reed MW, Camp NJ, Cox A (). Association of the TNFRSF10A and TNFRSF10B gene region on chromosome 8 with breast cancer risk [Abstract]. British Society for Human Genetics.
  25. Curtin K, Swierczek S, Lorenzo FR, Thomas A, Wang K, Prchal JT, Camp NJ (). A novel pairwise shared genomic segment statistic comparing cases and controls: application to polycythemia vera [Abstract]. American Society of Human Genetics, Montreal, Canada, October 11-15.
  26. Camp NJ, Parry M, Knight S, Abo R, Cannon-Albright LA, Elliott G, Rigas S, Balasubramanian SP, Cox A (). Fine-mapping CASP8 risk variants in Breast Cancer [Abstract]. American Society of Human Genetics, Montreal, Canada, October 11-15.
  27. Bigelow A, Lin W-Y, Burghel G, Connley D, Brock IW, Parry M, Rigas S, Cannon-Albright LA, Liu X, Ashelford K, Darby A, Cox A, Camp NJ (). Next generation sequence analysis using pipelines constructed in VisTrails: sequencing of the apoptosis genes CASP8, DR4 and DR5 to identify germ-line breast cancer risk variants [Abstract]. International Meeting on Human Genome Variation and Complex Genome Analysis, Berkeley, California, September 8-10.
  28. Andreotti G, Birmann B, De Roos A, Spinelli J, Cozen W, Camp NJ, Moysich K, Chiu B, Boffetta P, Benhaim-Luzon V, Brennan P, de Sanjose S, Costas Caudet L, Seniori Costantini A, Cocco P, Becker N, Foretova L, Maynadie M, Nieters A, Staines A, Milliken K, Weisenburger D, Baris D, Purdue M (). A pooled analysis of smoking and alcohol drinking and risk of Multiple Myeloma in the International Multiple Myeloma Consortium [Abstract]. American Association for Cancer Research Frontiers, Boston, Massachusetts, October 22-25.
  29. Parry M, Rigas SH, Reed MWR, Burghel G, Abo R, Camp NJ, Cox A (). Identification of novel variants in the breast cancer low peneätrance susceptibility gene, CASP8 [Abstract]. Breast Cancer Research Annual Meeting, London, UK, May 18.
  30. Rigas SH, Parry M, Reed MW, Camp NJ, Cox A (). Assessing the functional role of caspase-8 gene variants in breast cancer [Abstract]. Breast Cancer Research Annual Meeting, London, UK, May 18.
  31. Parry M, Elliott G, Abo R, Camp NJ, Neal DE, Donovan JL, Hamdy FC, Cox A (). Caspase-8 gene SNPs in prostate cancer susceptibility: a replication study [Abstract]. American Association for Cancer Research Annual Meeting, Washington, DC, April 17-21.
  32. Abo R, Parry M, Rigas SH, Cox N, Camp NJ (). Association of genetic variants in TNFRSF10B and breast cancer [Abstract]. American Association for Cancer Research Annual Meeting, Washington, DC, April 17-21.
  33. Rigas S, Parry M, Reed MW, Camp NJ, Cox A (). Assessing the functional role of Caspase-8 gene variants in breast cancer [Abstract]. Sheffield Medical School Annual Research Meeting, Sheffield, UK.
  34. Rigas SH, Parry M, Reed MW, Camp NJ, Cox A (). Assessing the functional role of Caspase-8 gene variants in breast cancer [Abstract]. Yorkshire Cancer Research Annual Meeting, Harrogate, UK, June 22, 2010.
  35. Cai Z, Cannon-Albright LA, Camp NJ, Thomas A (). Shared Genomic Segment analysis identifies a susceptibility locus for breast cancer at 14q23.3 [Abstract]. American Society for Human Genetics, Washington, DC, November 2-6.
  36. Abo R, Cox A, Reed MWR, Parry M, Rigas S, Camp NJ (). Gene-gene associations in the apoptosis pathway and breast cancer risk [Abstract]. American Society for Human Genetics, Washington, DC, November 2-6.
  37. Parry M, Elliott G, Abo R, Camp NJ, Neal DE, Donovan JL, Hamdy FC, Cox A (). Caspase-8 gene SNPs in prostate cancer susceptibility: a replication study [Abstract]. American Society for Human Genetics, Washington, DC, November 2-6.
  38. Knight S, Abo RP, Abel HJ, Thomas A, Camp NJ (). Shared Genomic Segment Analysis: The Power to Succeed Where GWAS Fails [Abstract]. International Genetic Epidemiology Society 2010 Annual Meeting, Boston, Massachusetts, October 10-12.
  39. Abo R, Camp NJ, Genetic Epidemiology of CLL Consortium (). Haplotype-mining in GWAS: application to data from the Genetic Epidemiology of CLL consortium [Abstract]. International Genetic Epidemiology Society 2010 Annual Meeting, Boston, Massachusetts, October 10-12.
  40. Teerlink CC, Farnham JM, Allen-Brady K, Horne BD, Camp NJ, Cannon-Albright LA (). Using publically available control data for GWAS - a simple strategy for genetic matching [Abstract]. American Society for Human Genetics, Washington, DC, November 2-6.
  41. Curtin K, Camp NJ, Lorenzo FR, Swierczek S, Prchal JT (). Investigating the genetic susceptibility of congenital polycythemia through shared genomic segment and linkage analysis in a unique extended family [Abstract]. International Genetic Epidemiology Society 2010 Annual Meeting, Boston, Massachusetts, October 10-12.
  42. Slager SL, Rabe KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Lanasa MC, Spector LG, Rassenti L, Leis JF, Camp NJ, Glenn M, Kay NE, Cunningham JM, Hanson CA, Marti GE, Weinberg JB, Morrison VA, Link BK, Call TG, Caporaso NE, Cerhan JR (). Investigation of CLL-susceptibility loci with monoclonal B-cell lymphocytosis (MBL) risk and confirmation of recently reported CLL-susceptibility loci [Abstract]. American Society of Hematology meeting.
  43. Lorenzo FR, Curtin K, Camp NJ, Prchal J (). Genetic investigation by shared genomic segment and linkage study of a unique family with Primary Familial and Congenital Polycythemia [Abstract]. American Society of Hematology Annual Meeting.
  44. Abo R, Camp NJ (). Genomewide haplotype association analysis in sub-threshold regions [Abstract]. Rocky Mountain Bioinformatics Conference, Snowmass Village, Colorado, Dec 10-12.
  45. Lanasa MC, Allgood SD, Slager SL, Camp NJ, Spector LG, Rassenti L, Kay NE, Gockerman JP, Goodman B, Strom SS, Call T, Cerhan JR, Leis JF, Marti GE, Goldin LR, Weinberg JB, Caporaso NE (2009). Family-associated monoclonal B lymphocytosis shows differences from CLL that suggest an indolent biology [Abstract]. American Society of Hematology, New Orleans, Louisiana, December 5-8.
  46. Goldin LR, Lanasa MC, Slager SL, Strom SS, Camp NJ, Cerhan JR, Spector LG, Leis JF, Morrison V, Fontaine L, Rabe K, Rassenti L, Allgood S, Abbasi FR, Kay NE, Call TG, Hanson CA, Weinberg JB, Marti GE, Caporaso NE (2009). Monoclonal B-cell Lymphocytosis is commonly observed among unaffected members of high risk CLL families [Abstract]. American Society of Hematology, New Orleans, LA.
  47. Knight S, Camp NJ (2009). Is correcting relatedness in family-samples is necessary? Evidence against common wisdom [Abstract]. International Genetic Epidemiology Society Meeting, Honolulu, HI, October 18-20, 2009.
  48. Abo R, Camp NJ (2009). Improved combined family and case-control haplotype analyses [Abstract]. International Genetic Epidemiology Society Meeting, Honolulu, HI, October 18-20, 2009.
  49. Knight S, Abo R, Camp NJ (2009). Shared genomic segment analysis: A powerful method for detecting rare risk variants [Abstract]. American Society of Human Genetics Meeting, Honolulu, HI, October 20-24, 2009.
  50. Carlquist JF, Horne BD, McKinney J, Camp NJ, Muhlestein JB, Mower CP, Park JJ, Nicholas ZP, Anderson JL (2009). Melting curve analysis for fine mapping of variants in 6 lipid-related genes: Implications for improving coronary risk classification [Abstract]. American Society of Human Genetics Meeting, Honolulu, HI, October 20-24, 2009.
  51. Abo R, Cai Z, Lin W-Y, Elliot G, Rigas SH, Bishop DT, Cannon-Albright LA, Neal DE, Donovan JL, Hamdy FC, Cox A, Camp NJ (2009). Identification of a shared CASP8 haplotype associated with multiple common cancers [Abstract]. American Society of Human Genetics Meeting, Honolulu, HI, October 20-24, 2009.
  52. Anderson JL, Horne BD, Camp NJ, Muhlestein JB, Hopkins PN, Cannon-Albright LA, Mower CP, Park JJ, Clarke JL, Nicholas ZP, McKinney JT, Carlquist JF, for the CorGen Investigators (2009). Joint Effects of Genetic Variants from Multiple Pathways on Risk of Premature Coronary Artery Disease [Abstract]. American Heart Association.
  53. Parry M, Rigas SH, Balasubramanian S, Reed MW, Burghel G, Camp NJ, Cox A (2009). Sequencing Breast Cancer Risk Haplotype Carriers in the Caspase 8 Gene [Abstract]. Yorkshire Cancer Research Annual Scientific Meeting, Harrogate, UK, June 24, 2009.
  54. Horne BD, Camp NJ, Carlquist JF, Anderson JL (2009). Modeling multiplicative SNP Interactions in the presence of an additive genetic risk score [Abstract]. International Genetic Epidemiology Society Meeting, Honolulu, HA, October 18-20, 2009.
  55. Horne BD, Camp NJ, Carlquist JF, Muhlestein JB, Mower CP, Park JJ, Anderson JL (2009). Genetic risk scores weighted by SNP effect on intermediate lipid phenotypes for application to coronary artery disease associations [Abstract]. American Society of Human Genetics Meeting, Honolulu, HI, October 20-24, 2009.
  56. Genetic Epidemiology of CLL Consortium (2009). Confirmation of a set of genetic susceptibility variants for chronic lymphocytic leukemia (CLL) [Abstract]. American Association for Cancer Research, Denver, Colorado.
  57. Cox A, Lin WY, Elliott G, Rigas SH, Bishop DT, Cannon-Albright LA, Cai Z, Camp NJ, Neal DE, Donovan JL, Hamdy FC (2009). An investigation of the role of the caspase-8 gene in prostate and colon cancer susceptibility using a SNP-tagging approach [Abstract]. American Association for Cancer Research 100th Annual Meeting, April 18 - 22, 2009, Denver, Colorado.
  58. Knight S, Camp NJ, Coon H, McMahon W (2008). Linkage analysis of a large Tourette Syndrome pedigree [Abstract]. American Society of Human Genetics Meeting, Philadelphia, Pennsylvania, November 11-15, 2008.
  59. Curtin K, Lin WY, George R, Katory M, Shorto J, Bishop DT, Cox A, Camp NJ (2008). Colorectal Cancer and XRCC2: A Three-center Meta Analysis [Abstract]. American Society of Human Genetics Meeting, Philadelphia, Pennsylvania, November 11-15, 2008.
  60. Knight S, Camp NJ (2008). Detection of Complex Genetic Patterns Using MDR [Abstract]. International Genetic Epidemiology Society, September 15-16, 2008, St Louis, MO.
  61. Christensen GB, Farnham JM, Camp NJ, Cannon-Albright LA (2008). Combined Genome-wide Linkage and Association Analysis of Utah prostate cancer pedigrees identifies significance at 8q12 [Abstract]. International Genetic Epidemiology Society, September 15-16, 2008, St Louis, MO.
  62. Horne BD, Carlquist JF, Camp NJ, Mower CP, Park JJ, Muhlestein, Anderson JL (2008). Genetic Associations with Coronary Disease from Integer and Lipid-Weighted Genetic Risk Score Algorithms for Six Lipid Metabolism Genes [Abstract]. American Society of Human Genetics Meeting, Philadelphia, Pennsylvania, November 11-15, 2008.
  63. Farnham J, Leachman S, Camp NJ, Cannon-Albright LA (2008). Genome-wide case control association study for familial Melanoma identifies 2 significant associations [Abstract]. International Genetic Epidemiology Society, September 15-16, 2008; American Society of Human Genetics, November 11-15, 2008.
  64. Piccolo SR, Camp NJ, Frey LJ (2008). Polygenic Model for Predicting Breast Cancer Risk via Genome-Wide Polymorphisms [Abstract]. National Library of Medicine Meeting, Bethesda, MD, July 8-9, 2008.
  65. Curtin K, Lin WY, George R, Katory M, Shorto J, Bishop DT, Cox A, Camp NJ (2008). Meta Genetic Association of Colorectal Cancer and SNPs at 8q24, 9p24 and SMAD7 [Abstract]. International Genetic Epidemiology Society, St Louis, MO, September 15-16, 2008,.
  66. Abo R, Camp NJ (2008). Haplotye Association Analysis: Power Gain from Phasing Under the Alternative Hypothesis? [Abstract]. International Genetic Epidemiology Society, September 15-16, 2008, St Louis, MO.
  67. Abo R, Lin W, Shepherd N, Cox A, Camp NJ (2008). Identification of CASP8 haplotypes associated with Breast Cancer using hapConstructor [Abstract]. American Association for Cancer Research Annual Meeting. April 12-16, 2008, San Diego, CA.
  68. Curtin K, Cox A, Cannon-Albright LA, Camp NJ (2008). The role of disease-based discovery panels in tSNP selection [Abstract]. American Association for Cancer Research Annual Meeting, San Diego, Caifornia, April 12-16, 2008.
  69. Abo R, Lin WY, Shepherd N, Balasubramanian SP, Reed MW, Cox A, Camp NJ (2008). Identification of CASP8 haplotypes associated with Breast cancer [Abstract]. National Library of Medicine Conference, Bethesda, MD, July 8-9, 2008.
  70. Shephard N, Abo R, Rigas S, Lin WY, Brock I, Shippen A, Balasubramanian, Reed MW, Frank B, Burwinkle B, Cannon-Albright LA, Camp NJ, Cox A (2008). A multi-centre study of CASP8 polymorphisms in breast cancer [Abstract]. Breast Cancer Campaign Conference, Breast Cancer Research, The Royal Society London, UK, May 2008, 10(suppl 2), P51.
  71. Thomas A, Camp NJ, Farnham JM, Allen-Brady K, Cannon-Albright LA (2007). Shared genomic segment analysis. A novel approach to mapping disease predisposition genes in extended pedigrees using dense single nucleotide polymorphism assays [Abstract]. International Genetic Epidemiology Society Meeting, York, England.
  72. Farnham JM, Camp NJ, Thomas A, Cannon-Albright LA (2007). A method to calculate the approximate density of SNPs required for successful linkage studies [Abstract]. International Genetic Epidemiology Society Meeting, York, England.
  73. Naiman N, Christensen GB, Wong J, Teerlink C, Thomas A, Camp NJ (2007). PCAtag: Software for selecting tagging-SNPs using principal components analysis [Abstract]. American Society of Human Genetics Meeting, San Diego, CA.
  74. Curtin K, Camp NJ (2007). Assessing the tSNP selection: Neutral versus disease-based discovery panels [Abstract]. American Society of Human Genetics Meeting, San Diego, CA.
  75. Christensen GB, Camp NJ, the ICPCG (2007). Focusing on linked pedigrees for localizaing disease genes: The sumLINK statistic applied to general and aggressive prostate cancer linkage data from the ICPCG [Abstract]. American Society of Human Genetics Meeting, San Diego, CA.
  76. Christensen GB, Camp NJ, the ICPCG (2007). The sumLINK statistic for linkage analysis: An application to the ICPCG pooled linkage resource [Abstract]. International Genetic Epidemiology Society Meeting, York, England.
  77. Camp NJ, Werner TL, Cannon-Albright LA (2007). Strong evidence for a genetic component to Multiple Myeloma and Pleiotropy with other hematologic malignancies [Abstract]. American Society of Human Genetics Meeting, San Diego, CA.
  78. Camp NJ, Werner TL, Cannon-Albright LA (2007). Multiple Myeloma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma: Evidence of overlapping genetic etiologies [Abstract]. International Genetic Epidemiology Society Meeting, York, England.
  79. Camp NJ, Farnham JM, Cannon-Albright LA (2007). Further localization of the 8q24 prostate cancer locus to a 2.0 Mb region using Utah extended pedigrees [Abstract]. American Association for Cancer Research Annual Meeting, Los Angeles, California.
  80. Camp NJ, Werner TL, Cannon-Albright LA (2007). The familiality of multiple myeloma in the Utah Population Database [Abstract]. American Association for Cancer Research Annual Meeting, Los Angeles, CA.
  81. Abo R, Wong J, Camp NJ (2007). Automatic haplotype construction in PedGenie [Abstract]. American Society of Human Genetics Meeting, San Diego, CA.
  82. Abo R, Thomas A, Camp NJ, Cannon-Albright LA (2007). Detecting genes involved in human disease by utilizing extended pedigrees and high-density genome wide markers [Abstract]. NLM Training Grant Meeting, CA.
  83. Abo R, Lin W, Shephard N, Cox A, Camp NJ (2007). Title Identification of CASP8 haplotypes associated with breast cancer using haploConstructor [Abstract]. AACR Annual Meeting, Los Angeles, CA.
  84. Horne BD, Camp NJ, Carlquist JF, Muhlestein JB, Kolek MJ, Nicholas ZP, Anderson JL (2006). Coronary disease associations of matrix metalloproteinases 1, 2, 3, & 9 and tissue inhibitor metalloproteinases 1, 2, & 3 [Abstract]. American Heart Association, Chicago, IL.
  85. Horne BD, Camp NJ, Carlquit JF, Muhlestein JB, Kolek MJ, Nicholas ZP, Anderson JL (2006). Polymorphisms in matrix metalloproteinases 1, 2, 3, & 9 and tissue inhibitor metalloproteinases 1, 2, & 3: Association to myocardial infarction [Abstract]. American Heart Association, Chicago, IL.
  86. Cannon-Albright LA, Farnham JM, Camp NJ (2006). Localization of a prostate cancer predisposition gene to a 416,515 bp region on chromosome Xq28 in Utah high-risk pedigrees [Abstract]. American Society of Human Genetics, New Orleans, LA.
  87. Camp NJ, Wong J, Thomas A (2006). Valid haplotype association analyses accounting for phase uncertainty [Abstract]. American Society of Human Genetics, New Orleans, LA.
  88. Christensen GB, Farnham JM, Camp NJ, Cannon-Albright LA (2006). Survey of excess familiality in prostate cancer [Abstract]. National Library of Medicine Informatics Training Meeting, Nashville, TN.
  89. Horne BD, Anderson JL, Camp NJ (2006). Classification and regression tree analysis for polygenic risk stratification [Abstract]. International Genetic Epidemiology Society Meeting, Tampa Bay, FL.
  90. Curtin K, Wong J, Allen-Brady K, Camp NJ (2006). PedGenie 2.0: meta Genetic Association Testing in Mixed Family and Case-Control Designs [Abstract]. American Society of Human Genetics, New Orleans, LA.
  91. Curtin K, Wong J, Allen-Brady K, Camp NJ (2006). PedGenie 2.0: meta genetic association testing in mixed family and case-control designs [Abstract]. International Genetic Epidemology Society Meeting, Tampa Bay, FL.
  92. Christensen GB, Camp NJ, Farnham JM, Cannon-Albright LA (2006). Genome-wide linkage analysis for aggressive prostate cancer in Utah high risk pedigrees [Abstract]. American Society of Human Genetics, New Orleans, LA, October 9-13, 2006.
  93. Christensen GB, Camp NJ, Farnham JM, Cannon-Albright LA (2006). Genetic susceptibility of prostate Cancer: Genome-wide screen of men with non-metastatic disease [Abstract]. International Genetic Epidemology Society Meeting, Tampa Bay FL.
  94. Camp NJ, Farnham JM, Cannon-Albright LA (2006). Localization of a Prostate Cancer Predisposition Gene to an 880 kilobase region on chromosome 22q12.3 in Utah high-risk pedigrees [Abstract]. International Genetic Epidemology Society Meeting, Tampa Bay, FL.
  95. Teerlink C, Camp NJ, Cannon-Albright LA (2006). Genome-wide linkage analyses for asthma predisposition loci in extended Utah pedigrees [Abstract]. International Genetic Epidemiology Society Meeting, Tampa Bay, FL.
  96. Horne BD, Anderson JL, Carlquist JF, Muhlestein JB, Camp NJ (2006). Multi-SNP genetic risk scores increase power to predict clinical disease phenotypes [Abstract]. American Society of Human Genetics, New Orleans, LA.
  97. Allen-Brady K, Horne BD, Malhotra A, Teerlink, Camp NJ, Thomas A (Accepted). Analysis of high-density SNP data: three novel methods that control for linkage disequilibrium between markers [Abstract]. Genetic Analysis Workshop 15, Tampa Bay, FL.
  98. Allen-Brady K, Farnham JM, Camp NJ, Ostrander EA, Karlins E, Cannon-Albright LA (2006). BRCA2 mutations in Utah high-risk prostate cancer pedigrees [Abstract]. American Society of Human Genetics, New Orleans, LA.
  99. Camp NJ, Farnham JM, Cannon-Albright LA (2005). Evidence for a prostate cancer predisposition locus on chromosome 22q in the Utah pedigrees [Abstract]. American Society of Human Genetics, Salt Lake City, UT.
  100. McKinney JT, Dobrowolski SF, Tend D, Cutler L, Ellingson C, Wall M, Cannon-Albright L, Camp NJ, Horne B, Carlquist J, Hopkins P, Anderson J (2005). A collaborative investigation of 6 genes related to HDL-cholesterol metabolism -- SNP discovery phase for the risk burden of HDL haplotypes project [Abstract]. Human Genome Variation Society Meeting, Salt Lake City, UT.
  101. Horne BD, Carlquist JF, Anderson JL, Mower CP, Camp NJ (2005). Phylogeny-Based Haplotype Association Analysis for Coronary Artery Disease and the Cholesteryl Ester Transfer Protein Gene [Abstract]. American Society of Human Genetics Meeting, Salt Lake City, UT.
  102. Mower CP, Camp NJ, Horne BD, Anderson JL, Clarke JL, Kolek MJ, McKinney JT, Carlquist JF (2005). Differential Prediction of Coronary Artery Disease among Diabetics by CETP Tagging SNPs [Abstract]. American Society of Human Genetics Meeting, Salt Lake City, UT.
  103. Cannon-Albright LA, Farnham JM, Camp NJ (2005). Using a Utah Pseudo-Isolate Population to Identify Predisposition Genes for Prostate Cancer [Abstract]. American Society of Human Genetics Meeting, Salt Lake City, UT.
  104. Allen-Brady K, Wong J, Camp NJ (2005). REGENERATOR: An analysis tool for genetic association testing in extended pedigrees and genealogies [Abstract]. American Society of Human Genetics Meeting, Salt Lake City, UT.
  105. Camp NJ, Hulme L, Reed MW, Cox A (2005). Investigating Interactions Between Variants in Multiple Candidate Genes and Association with Breast Cancer [Abstract]. International Genetic Epidemiology Society Meeting, Park City, UT.
  106. Camp NJ, Hulme L, Reed MW, Cox A (2005). Patterns of Linkage Disequilibrium for XRCC3 in Breast Cancer Cases and Controls and Haplotypes Associated with Breast Cancer [Abstract]. International Genetic Epidemiology Society Meeting, Park City, UT.
  107. Allen-Brady K, Camp NJ (2005). Linkage Analysis of DNA Repair genes in High-Risk Utah Breast Cancer Families [Abstract]. International Genetic Epidemiology Society Meeting, Park City, UT.
  108. Horne BD, Camp NJ, Anderson JL, Mower CP, Clarke JL, Kolek MJ, McKinney JT, Carlquist JF (2005). Assessment of Associations between Coronary Artery Disease and Genetic Variants in the Cholesteryl Ester Transfer Protein Gene using Tagging-SNPs and a Test-Validation Study Design [Abstract]. American Heart Association, Dallas, TX.
  109. Allen-Brady K, Camp NJ, Ward J, Cannon-Albright LA (2004). Familiality Analysis of Ductal and Lobular Breast Cancer in hte Utah Population Database [Abstract]. National Library of Medicine Director's Training Meeting.
  110. Allen-Brady K, Camp NJ (2005). Analysis of tagging-SNPs in double-strand DNA repair genes in high-risk breast cancer families. Abstract #1329 [Abstract]. AACR Annual Meeting, Anaheim, CA, 46, 309-320.
  111. Cannon-Albright LA, Farnham JM, Camp NJ (2005). Using a Utah pseudo isolate population to identify predisposition genes for prostate cancer [Abstract]. Second International Meeting on Genetics of Complex Diseases and Isolated Populations, Paestum, Italy, May 28 - 31, 2005.
  112. Allen-Brady K, Camp NJ, Ward J, Cannon-Albright LA (2004). Familiality Analysis of Ductal and Lobular Breast Cancer in the Utah Population Database [Abstract]. Susan G. Komen Mission Conference: Pathways to Promise.
  113. Donaldson AE, Donaldson DL, Camp NJ, Backus S, Rose J, Cannon-Albright LA (2004). Familial Association of type 1 diabetes (T1D) and multiple sclerosis (MS) as defined by mortality data from a population-based genealogical database [Abstract]. Auto-immune Conference.
  114. Horne BD, Carlquist JF, Muhlestein JB, Anderson JL, Camp N (2004). Linkage Disequilibrium Structure and Selection of Tagging-SNPs are Insensitive to Phenotype: CETP and Coronary Artery Disease [Abstract]. Am J Hum Genet.
  115. Camp NJ, Lowry MR, Richards RL, Plenk AM, Hughes DC, Cannon-Albright LA (2004). Genome-wide Linkage Analysis of Recurrent, Early-Onset Major Depression and Anxiety Disorders in Extended Utah Pedigrees [Abstract]. Am J Hum Genet.
  116. Allen-Brady K, Camp NJ (2004). Characterization of the linkage disequilibrium structure and identification of tagging-SNPs in XRCC4 [Abstract]. Am J Hum Genet.
  117. Cannon-Albright LA, Farnham JM, Leachman S, Camp NJ (2004). Linkage evidence for Cutaneous Malignant Melanoma to 1p22 in Utah Pedigrees [Abstract]. Am J Hum Genet.
  118. Berthelemy-Okazaki N, Camp NJ, Farnham J, Thomas A, Zhang K, Cannon-Albright LA (2004). Examination of ELN as a candidate gene in the Utah Intracranial Aneurysm Pedigree Resource [Abstract]. Am J Hum Genet.
  119. Cannon-Albright LA, Farnham JM, Thomas A, Camp NJ (2003). A new perspective on the prospects of genealogical / medical data resources - the Utah example [Abstract]. IGES Proceedings 2003, 24, A20.
  120. Thomas A, Camp NJ (2003). Graphical modeling of the joint distribution of alleles at associated loci [Abstract]. Am J Hum Genet, 73(Suppl 1), 193 A159.
  121. Camp NJ, Farnham JM, Thomas A, Cannon-Albright LA (2003). A Utah Pseudo-Isolate: Proof of Concept using Longevity [Abstract]. Am J Hum Genet, 73(Suppl 1), 336 A1143.
  122. Horne BD, Camp NJ (2003). Principal Component Analysis for Selection of Optimal SNP-sets that Capture Intragenic Genetic Variation [Abstract]. Am J Hum Genet, 73(Suppl 1), 379 A1223.
  123. Camp NJ, Farnham JM, Thomas A, Cannon-Albright LA (2003). Familiality of Longevity in a Utah Pseudo-Isolate [Abstract]. Genetics of Complex Diseases and Isolated Populations, 23 -76.
  124. Swensen J, Camp NJ, Farnham J, Tavtigian SV, Cannon-Albright LA (2003). Involvement of RNASEL in chromosome 1-linked Utah high-risk prostate cancer pedigrees [Abstract]. Proceedings of American Association for Cancer Research, A3603.
  125. Hunt SC, Hasstedt SJ, Coon H, Camp NJ, Cawthon RM, Wu LL, Hopkins PN (2002). Linkage of Creatinine Clearance to Chromosome 10 In Utah Pedigrees Replicates the Locus for End-Stage Renal Disease in Humans and Renal Failure in the Fawn-Hooded Rat [Abstract]. American Heart Association Conference on Cardiovascular Disease Epidemiology and Prevention.
  126. Horne BD, Farnham JM, Cannon-Albright LA, Camp NJ (2002). Comparison of Parametric methods for Genome-wide scanning of Extended Pedigrees in the Framingham Heart Study, with Application to the TG/HDL Ratio [Abstract]. Genetic Analysis Workshop 13, 507-11.
  127. Allen-Brady K, Farnham JM, Weiler J, Camp NJ (2002). Application of an Empirical Association Method in Extended Pedigrees [Abstract]. Genetic Analysis Workshop 13, 487-91.
  128. Ray KK, Bennett CE, Camp NJ, Francis SE, Crossman DC (2002). IL-1 cytokine polymorphisms predicts Troponin-T positive status and therefore identifies high risk patients during acute coronary syndromes [Abstract]. Heart, 87(Suppl 2), 63.
  129. Ray KK, Camp NJ, Bennett CE, Francis SE, Crossman DC (2002). Potential role for the IL-1 locus in coronary artery disease: a comparison of stable and unstable disease [Abstract]. JACC, 39(Suppl), 188-9 B.
  130. Camp NJ, Tavtigian SV (2002). Meta analysis of association of SNPs in HPC2 and prostate cancer [Abstract]. Proceedings of the International Genetic Epidemiology Society Meeting, A22, 26.
  131. Cannon Albright L, Farnham J, Camp NJ, Neuhausen S, Wood G, ONeil G, Buswell H, Tsuruda J, Parker D, MacDonald J (2002). Confirmation of the mapping of an Intracranial Aneurysm Predisposition Locus to Chromosome 7 [Abstract]. Am J Hum Genet, 71(Suppl), 432.
  132. Neuhausen SL, Csokay B, Farnham J, Camp NJ, Nathanson K, Rebbeck T, Weber B, Tavtigian S, Cannon-Albright L (2002). Association of Two HPC2/ELAC2 Missense Variants with Risk of Breast Cancer [Abstract]. Proceedings of Era of Hope Department of Defense Breast Cancer Research Program Meeting.
  133. Swensen J, Farnham JM, Camp NJ, Cannon-Albright LA, Tavtigian SV (2002). Tiered Case-Control Analysis of Candidate Prostate Cancer Moderate Risk Variants [Abstract]. Proceedings of American Association for Cancer Research, 43, 929 A4603.
  134. Cannon-Albright LA, Farnham JM, Camp NJ, Swensen J, Tavtigian SV (2002). A Genomic Search in Utah Colorectal Cancer Pedigrees [Abstract]. Proceedings of American Association for Cancer Research, 43, 566 A2808.
  135. Ray KK, Camp NJ, Bennett CE, Francis CE, Crossman DC (2001). Differential regulation of endothelial function and systemic inflammation by gene variation at the IL-1 locus during acute respiratory syndromes [Abstract]. Circulation, 104,17(Suppl 2), 390.
  136. Ray KK, Camp NJ, Bennett CE, Francis SE, Crossman DC (2001). Polymorphism at the IL-1 locus determines the endothelial but not the systemic response in acute respiratory syndromes [Abstract]. Eur Heart J, 22(Suppl), 373 A2012.
  137. Cox A, Camp NJ, diGiovine FS, Dale M, John S, Worthington J, Ollier WER, Silman AJ, Duff GW (2001). Genetic linkage of the Interleukin-1 gene cluster to erosive rheumatoid arthritis [Abstract]. Ann Rheum Dis.
  138. Camp NJ, Farnham JM (2001). A simulation-based method for applying standard statistical tests to extended pedigree data [Abstract]. Am J Hum Genet, 69, A1353.
  139. Camp NJ, Myles-Worsley M (2000). Narrowing the Region for a Schizophrenia Locus to 4.6 cM on Chromosome 2 in Large Palauan Pedigrees [Abstract]. Schiz Res, 49(S), 67.
  140. Camp NJ, Read RC, diGiovine FS, Barrow R, Kaczmarski EB, Chaudhary AGA, Fox AJ, Duff GW (2000). An interleukin-1 genotype is associated with outcome of meningococcal disease [Abstract]. Am J Hum Genet, 228, A1235.
  141. Cox A, Camp NJ, diGiovine FS, Silman AJ, Ollier WER, Worthington J, Duff GW (1999). Association versus linkage studies. A comparison of the sib-TDT and non-parametric linkage analysis in Rheumatoid Arthritis [Abstract]. Genet Epidemiol, 15, A56.
  142. Cox A, Camp NJ, Dale M, diGiovine FS, Kay L, Walker DJ, Duff GW (1999). A possible role for the Interleukin-1 genes in early onset psoriatic arthritis [Abstract]. Am J Hum Genet, 65, A246.
  143. Camp NJ, Cox A, McCabe D, Duff GW (1999). The relationship between IL-1 genotype and clinical response to recombinant IL-1 receptor antagonist therapy for rheumatoid arthritis [Abstract]. Am J Hum Genet, 65, A198.
  144. Cox A, Camp NJ, Dale M, diGiovine FS, Silman AJ, Ollier WER, Worthington J, Duff GW (1998). Linkage disequilibrium mapping of rheumatoid arthritis severity/susceptibility loci in candidate genes using the TDT and sib-TDT [Abstract]. Am J Hum Genetics, 63, A286.
  145. Dewberry RM, Camp NJ, Gunn J, Burton AJ, Carter ND, Jeffrey S, Syriss P, Kaski JC, Cumberland DC, Duff GW, Crossman DC, Francis SE (1998). Interleukin-1 (IL-1) gene polymorphisms risk of coronary arterial disease [Abstract]. Heart, 79(1), 147.
  146. Carter MJ, Jones S, Mansfield JC, diGiovine FS, Camp NJ, Lobo AJ, Duff GW (1998). Further Evidence of an Association between the Allele 2 of the Interleukin-1 Receptor Antagonist (IL-1RN) Gene Polymorphism and Ulcerative Colitis (UC) [Abstract]. Gastroenterology, 114, A918.
  147. Carter MJ, Jones S, diGiovine FS, Camp NJ, Lobo AJ, Duff GW (1998). Allele 2 of the Interleukin-1 Receptor Antagonist Gene Polymorphism is Associated with Reduced Expression of Interleukin-1 Receptor Antagonist in Ulcerative Colitis [Abstract]. Gastroenterology, 114, A917.
  148. Camp NJ (1997). Genome-wide Association Studies; Sample Sizes necessary, and the effect of the Mode of Inheritance of the Disease [Abstract]. Ann Hum Genet, 61, 535-6.
  149. Reid JG, Richardson D, Newstead CG, Camp NJ, Duff GW, Gooi HC (1997). Association between genetic polymorphisms of Tumour Necrosis Factor and Interleukin-1 in Acute Renal Allograft rejection [Abstract]. Eur J Immunogenet, 24(1), 64.
  150. Richardson PSR, diGiovine FS, Cox A, Gonzalez AM, Camp N, Rennie IG, Talbot JF, Ward JD, Duff GW (1997). Interleukin-1 gene polymorphisms are associated with sight-threatening diabetic retinopathy [Abstract]. Invest Opthalmol Vis Sci, 38(20), 3714.
  151. Cox A, Camp NJ, Nicklin MJH, Duff GW (1997). An analysis of linkage disequilibrium in the IL-1 gene cluster [Abstract]. Am J Hum Genet, 61(4), A272.
  152. Camp NJ, Cox A, Gonzalez AM, El Nahass AM, Shaw J, Boulton AJM, Ward JD, Duff GW (1997). The interleukin-1 genes and their role in diabetic nephropathy [Abstract]. Cytokine, 9(11), 907.
  153. Cox A, Camp NJ, Gonzalez AM, El Nahass AM, Shaw J, Boulton AJM, Ward JD, Duff GW (1997). Haplotypes of the IL-1 gene cluster in Diabetic Nephropathy [Abstract]. Genet Epidemiol, 14(5), 523.
  154. Gordon MA, Gleeson D, Oppenheim E, diGiovine FS, Camp NJ, Duff GW (1996). Tumour Necrosis Factor: Genetic polylmorphisms and primary biliary cirrhosis [Abstract]. Hepatology, 24(4), 159.
  155. Duff GW, diGiovine FS, Wilson AG, Nicklin M, Cox A, Camp N (1996). Cytokine Polymorphisms and Rheumatic Diseases [Abstract]. Eur Cytokine Netw, 7(3), 433.
  156. Cannings C, Camp N, Sheehan N (1994). On the number of genotypic states for a genealogy [Abstract]. Genet Epidemiol, 11(3), 88.

News

Video